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2. Abbreviations
A3P5P   Adenosine 3’, 5’ diphosphate
ADP  Adenosine 5’-diphosphate 
ARMX  AR-C69931MX N6-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-β,γ-
dichloromethylene-ATP
Btk Bruton’s tyrosine kinase
Gp  Glycoprotein
GEF  Guanosine nucleotide exchange factor
LY294002  2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
PAR   Protease-activated receptor
PAR1-AP Protease-activated receptor 1-activating peptide (peptide SFLLRN)
PAR4-AP  Protease-activated receptor 4-activating peptide (peptide AYPGKF)
PDK-1  Phosphoinositide-dependent kinase 1
PI  Phosphatidylinositol
PI3K  Phosphatidylinositol 3-kinase
PI3K-IA  Phosphatidylinositol 3-kinase class IA
PI(3)P  Phosphatidylinositol 3-phosphate
PI(3,4)P
2
 Phosphatidylinositol 3,4-bisphosphate
PI(4,5)P
2
 Phosphatidylinositol 4,5-bisphosphate
PI(3,4,5)P
3
 Phosphatidylinositol 3,4,5-trisphosphate
PKC  Protein kinase C
PLC  Phospholipase C
SH  Src homology
VWF  von Willebrand factor
*Note. Only those abbreviations used more than three times in the text are listed
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3. Abstract
 
Thrombosis occurs at sites of vascular injury, such as the erosion or rupture of an unstable 
atherosclerotic plaque. In the injured arterial vessel, high levels of shear stress and the exposure 
of subendothelial collagen trigger platelet responses initiated by the interaction between 
von Willebrand factor (VWF) and the platelet glycoprotein (Gp) Ib-IX-V receptor. This 
brief interaction activates platelets and reduces the speed of platelet translocation allowing 
the interaction of exposed collagen with the α2β1 and GpVI receptors. The net effect of 
the interaction between subendothelial matrix and platelet adhesion receptors is increased 
activation and secretion of proaggregatory molecules such as ADP. Secreted ADP amplifies 
platelet responses and enhances the activation of the αIIbβ3 receptor. Activated platelets also 
expose membrane phospholipids, mainly phosphatidylserine creating a suitable surface for the 
assembly of coagulation factors leading to local thrombin generation. 
Thrombin, a serine protease, stimulates platelets mainly through the cleavage of protease-
activated receptor (PAR) 1 and PAR4. Thrombin stimulates many proaggregatory-signaling 
pathways, including phosphatidylinositol 3-kinase (PI3K); this enzyme regulates major platelet 
responses like shape change and aggregation. Although PI3K mediates key platelet responses, 
the mechanisms by which this enzyme is activated downstream of thrombin are not well 
understood. Furthermore, mechanisms of PI3K activation in platelets stimulated by shear stress 
are unknown. Our work focused on unraveling mechanisms of PI3K activation in shear stress- 
and thrombin-stimulated platelets.
In platelets isolated from healthy volunteers, pathological shear stress (120 d/cm²) causes 
phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P
3
) production and thrombin stimulation 
causes Akt phosphorylation, indicating that both stimuli cause the activation of PI3K. PI3K 
immunoprecipitations and Western blots of shear stress or thrombin-stimulated platelets 
showed that PI3K associates with tyrosine phosphorylated proteins. Treatment of platelets with 
a tyrosine kinase inhibitor abolishes PI(3,4,5)P
3
 production and inhibits Akt phosphorylation 
indicating a role for tyrosine phosphorylated proteins in regulating PI3K activity. Inhibition 
studies revealed that the P2Y
12
 receptor of ADP plays a crucial role in PI3K activation when 
platelets are stimulated by shear stress, or thrombin. Inhibition of PI3K or P2Y
12
 significantly 
decreases platelet aggregation induced by shear stress of through the PAR1.
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In resting platelets PI3K associates with a complex of α-actinin and phosphatidylinositol 
4,5-bisphosphate (PI(4,5)P
2
). Shear stress triggers the development of a dynamic interaction 
between PI3K-α-actinin-PI(4,5)P
2
 that correlates with PI(3,4,5)P
3
 production, suggesting that α-
actinin regulates PI3K activity by co-localizing it with substrate.
The results provide an explanation to the success of drugs targeting the P2Y
12
 receptor (e.g. 
Clopidogrel) when treating patients at risk of developing arterial thrombosis; and present a new 
set of possible targets to mediate platelet thrombosis through the regulation of PI3K activation.
12
REVIEW OF THE LITERATURE
13
REVIEW OF THE LITERATURE
4. Review of the literature
4.1. Platelet function in hemostasis and thrombosis
The hemostatic system evolved to arrest blood flow at sites of vascular injury to stop bleeding. 
Hemostasis is ensured by three major components, first described by the prominent pathologist 
Rudolph Virchow in 1856: the vessel wall, blood flow and blood constituents (cellular and 
soluble) (Fig. 1 A) (Virchow, 1856). A fine balance between the procoagulant and anticoagulant 
properties of these components is required to maintain blood fluidity. And an alteration in any of 
the components of this triad may result in bleeding or thrombosis (Vaughan et al., 1996).
Blood flow in arteries and veins differs sharply in one characteristic, flow velocity, arteries 
generally present relatively high flow velocities while flow velocities in veins are considerably 
Figure 1. Simplified scheme of arterial thrombus formation. (A) Healthy vessel portraying Virchow’s 
triad, vessel wall, blood flow and blood constituents. Note how the bigger red blood cells displace the 
smaller platelets keeping them near the vessel wall. (B) Presence of an atherosclerotic plaque disturbs 
the hemostatic balance by affecting the blood flow, generating pathological levels of shear stress, note 
how the cells are “squeezed” through the narrow vessel. (C) Platelet adhesion. Plaque rupture removes 
endothelial cells and exposes collagen triggering swift platelet responses that initiate with platelet 
adhesion. (D) Platelet aggregation. Adhered platelets become activated, secrete proaggregatory granules 
and activate integrins to recruit other platelets (aggregate) to the injured site for thrombus growth (F) 
Thrombus stabilization. Activated platelets express phospholipids in their surfaces allocating coagulation 
factors to locally generate thrombin, which then acts as a potent platelet activator and cleaves fibrinogen 
into fibrin stabilizing the platelet thrombus.
Platelets
Endothelial cells
RBC
Leukocytes
Collagen fibrils
Fibrin deposition
A
C D
E
Lipid core
B
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slower (Kao and McIntire, 2003). This difference in velocities explains why thrombi in 
veins consists mainly of fibrin and red blood cells “red thrombus”, while arterial thrombi 
is mainly composed of platelets “white thrombus” (Jorgensen and Torvik, 1966;Jorgensen, 
1964;Friedman and Van den Bovenkamp, 1966). In veins, the coagulation factors (coagulation 
cascade) leading to thrombin generation and fibrin deposition (with entrapment of red blood 
cells) play a fundamental role in thrombus formation to prevent blood loss. In arteries, the 
rapid blood flow ”washes” away the circulating coagulation factors; therefore platelet-platelet 
contacts ”platelet aggregation” becomes fundamental in the development of the thrombus. This 
is not to say that thrombin generation is irrelevant but rather it potentiates platelet responses and 
plays an important role in thrombus stabilization through the generation of insoluble fibrin once 
the vessel lumen narrows and the blood flow is close to none (Kao and McIntire, 2003).
Unfortunately coagulation is not unique to arrest bleeding. Under certain pathological 
conditions the thrombus forms within the blood vessel, if the thrombus forms in an artery and 
blood flow ceases, this causes ischemia and if not resolve necrosis of the tissue previously 
irrigated by that vessel. This pathological thrombus (thrombosis) is precipitated by alterations 
in the endothelium, like in patients suffering from atherosclerosis (Fig. 1 B). At these sites the 
arterial lumen narrows altering one of the components of the triad, the blood flow. Blood flows 
in an infinite number of infinitesimal laminae, and the difference in velocity between laminae 
generates shearing forces known as shear stress. At sites of atherosclerosis the blood is thrust 
through a narrowed vessel and the difference in velocities between laminae of flowing blood 
sharply increase generating pathological levels of shear stress (> 60 d/cm2), which by itself 
causes platelet activation (Kroll et al., 1996). If the atherosclerotic plaque erodes or ruptures 
subendothelial collagen is exposed triggering platelet responses. Platelets adhered to the injured 
site, get activated (change shape, secrete proaggregatory granules, activate integrins) and finally 
recruit other platelets (aggregate) to the site of injury to close the vessel (Fig. 1 C-D). Activated 
platelets also expose phospholipids in their surface allowing the formation of “tenase” and 
“prothrombinase” complexes, allocating the generation of thrombin, the most potent platelet 
activator, to the site of injury (Kroll, 2001;Monroe et al., 2002). Locally generated thrombin, 
besides stabilizing the thrombus through fibrin generation (Fig. 1 E), it also initiates and 
potentiates platelet responses such as the activation of phosphatidylinositol 3-kinase (PI3K) an 
enzyme that modulates platelet responses like shape change and aggregation.
In the next sections the mechanisms leading to thrombus formation under shear stress 
conditions and in the presence of thrombin will be discussed. A section will be dedicated to the 
molecule of our interest the PI3K enzyme.
4.2. Shear stress-induced platelet responses
 
The recognition of shear stress as a platelet activator was reported in the mid-70’s (Brown III, 
et al., 1975;Turitto and Baumgartner, 1975). Thereafter, a constant development of devices 
to analyze the effects of shear forces on platelet function has improved our understanding of 
how mechanical forces trigger platelet responses. The recognition that the interaction between 
the platelet glycoprotein (Gp) Ib-IX-V complex and von Willebrand factor (VWF) regulate 
responses to high levels of shear stress was an important step further in our understanding of 
how rheological forces regulate platelet thrombus formation (Moake et al., 1986).
14
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 4.2.1. Principles of rheology
Rheology is the study of the deformation and flow of materials (G. rheos–flow, current, stream 
+ logo–study). To model blood flow we can simply consider the vasculature as a cylindrical 
tube in which blood behaves as a Newtonian fluid (where the flow rate of a fluid is proportional 
to the applied force). Blood flows in an immeasurable number of infinitesimally small layers 
having different velocities and the difference in these laminar velocities is designated as shear 
rate (γ, expressed in cm/s or s-1). The layer in close contact with the vessel wall is considered to 
be motionless, therefore having the greatest shear rate; in contrast the fastest layer, with a shear 
rate of cero is the layer in the center of the tube (Fig. 2) (De Groot, 2003;Kroll et al., 1996). 
Based on the assumption that blood behaves as a Newtonian fluid, shear rates can be converted 
to fluid shear stresses, defined as the force per unit area applied to blood in the direction of the 
flow. Shear stress (τ) = (μ) (γ)  where μ is the viscosity of blood. Based on this formula wall 
shear stresses in vivo have been calculated (Table 1) (De Groot, 2003;Kroll et al., 1996). Of 
Figure 2. Depiction of blood flow in a cylindrical chamber. Blood flows in an infinite number of 
laminae that generate a parabolic flow velocity (v) where the laminae at the center of the tube have the 
maximal velocity, while the ones next to the vessel wall are motionless. The difference in velocities 
between different laminae generates shear forces, and the velocity gradient is greatest near the vessel 
wall, therefore the maximal shear rate (γ) is present at the vessel wall.
note is that the biggest differences in the shear rates are always those in close proximity to the 
vessel wall, therefore the calculated shear stress is that nearest to the wall, known as wall shear 
stress, which is the force that flowing viscous blood exerts on the vessel wall. 
One function of the cardiovascular system is convection (mass movement of fluid caused by a 
difference in pressure between two points). Convection is in fact a determining factor for the 
transport of platelets to the vessel wall. Studies have demonstrated that at shear rates above 
1500 s-1 red blood cells concentrate to the center of the flow pushing the smaller platelets to the 
periphery increasing their concentration near the vessel wall facilitating their haemostatic role 
(Fig. 1 A, B) (Aarts et al., 1988;Goldsmith, 1971;Cokelet, 1980).
Blood flow is a complicated event influenced by several factors like a pumping heart generating 
pulsatile flow, branching arteries where the blood flow is almost tangential to the vessel wall 
and changes in blood viscosity, which in diseases such as diabetes mellitus and polycythemia 
vera can be greatly increased. In vitro models to study thrombus formation are limited in 
copying all the different factors that affect blood flow and consequently platelet responses, 
but these models enable us to understand the hemodynamic effects of blood flow on platelet 
v = 0 at the wall � = maximal at the wall
v = maximal at the center ��� = 0 at the center
--------------------------------------------------------------------------------------------
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function (Kao and McIntire, 2003). 
One useful model is the cone-plate 
viscometer. This model is able to 
generate constant shear forces varying 
from 2 to 300 d/cm², the desired level 
of shear stress is rapidly achieved, thus 
the sample can be exposed to a constant 
level of shear stress for different periods 
of time, the temperature of the plates 
can be controlled and one big advantage 
is that the sample can be quickly 
recovered and subjected to biochemical 
analysis (Fig. 3) (Kao and McIntire, 
2003;Kroll et al., 1996). 
Arteria femoralis
Aorta ascendens
Capillaries
Small arteries
Veins
Stenosed arteries
350
50 - 300
2,000 - 5,000
500 - 1600
20 - 200
800 - 40,000
11
2-10
Not applicable*
19 - 60
0.7 - 7
30 - 1,500
Vessel
Wall shear rates and wall shear stresses in different human vessels.
Assuming that the viscosity of blood is 0.038 poise
Wall Shear stress
(dynes/cm )2
Wall shear rate
(s )-1
Table 1. Calculated shear forces present in different human vessels. * Calculations for 
capillaries are not meaningful since flow regimen and bulk viscosity are not applicable. 
Data adapted from Kroll MH et al (Kroll et al., 1996) and de Groot PG (De Groot, 2003). 
Figure 3. The cone-plate viscometer consists of a 
rotating cone over a flat plate, and the shear stress is 
proportional to the cone angle and the rotation rate. 
This device generates shear stresses that are constant 
and uniform throughout the fluid sample.
 4.2.2. Effects of shear stress on platelet adhesion 
Platelets patrol the vascular wall as a first defense against blood loss. When the endothelium 
is damaged platelets swiftly react by adhering to the exposed subendothelium matrix (Fig. 1 
C). The first step of platelet adherence is directed by several receptors and components in the 
subendothelial matrix; the first contacts between receptors and matrix components depend to a 
large extent on the shear stress present at the site of vascular injury (Ruggeri et al., 1999;Savage 
et al., 1998). When vascular injury occurs at sites of low shear stress, subendothelial matrix 
proteins such as collagen, VWF, fibronectin, laminin and fibrinogen are responsible for the 
recruitment of platelets to the injured site. When vascular injury occurs at sites of elevated 
shear stress, mainly VWF and collagen are responsible for the initial recruitment of platelets 
via bonds with platelet receptors that can withstand harsh frictional forces that would otherwise 
detach the platelets. In here, I only discuss the best-characterized receptors known to participate 
in platelet adhesion. 
Plate
Cone
Sample
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I. Receptors involved in platelet adhesion
 
 I.I. Glycoprotein Ib-IX-V
The GpIb-IX-V complex is composed of four subunits GpIbα, GpIbβ, GpIX and GpV, there are 
approximately 25,000 copies of this receptor per platelet (Lopez, 1994). This receptor is able to 
bind several ligands, including coagulation factors thrombin, high molecular weight kininogen, 
factor XI and XII (Baglia et al., 2002;Bradford et al., 1997;Canobbio et al., 2004) and 
glycoproteins p-selectin and Mac-1 (Fig. 4) (Romo et al., 1999;Simon et al., 2000). But it is the 
interaction of this receptor with VWF that mediates platelet adhesion and platelet aggregation 
under conditions of high shear stress (Savage et al., 1998). Although VWF circulates freely 
in blood, it is unable to bind GpIb-IX-V under physiological conditions; their interaction is 
triggered by the immobilization of VWF to endothelial surface or the exposure of platelets 
and VWF to high levels of shear stress (>30 d/cm2) (Savage et al., 1998). Platelet adhesion to 
damaged vessel walls where the shear stress is low like in veins is independent of GpIb-IX-
V, but it becomes GpIb-IX-V dependent as the levels of shear stress rise and at conditions of 
Figure 4. Glycoprotein Ib-IX-V and integrin αIIbβ3. Four subunits GpIbα, GpIbβ, GpIX 
and GpV compose the GpIb-IX-V complex; two subunits αIIb and β3 compose the αIIbβ3 
integrin. Extracellular binding partners are shown (ligands). Molecular partners associated 
with the cytoplasmic tails of GpIb-IX-V and αIIbβ3 are shown. Numbers indicate location 
of amino acids and lines the approximate place where the binding takes place. 
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elevated arterial wall shear stress (>30 d/cm2), platelet tethering depends on the VWF-GpIb-IX-
V interaction (Savage et al., 1998). Endothelial damage leads to the exposure of collagen; VWF 
(locally present in the subendothelium, from plasma or platelet-secreted) adheres to collagen 
and forms long strands that are recognized by GpIb-IX-V forming a reversible interaction that 
allows platelets to roll and slow, thus allowing other platelet receptors time to interact with 
the thrombogenic matrix (Fredrickson et al., 1998). The interaction VWF-GpIb-IX-V initiates 
platelet activation sufficient to turn on other receptors like α2β1 and αIIbβ3 (Cruz et al., 
2004;Kasirer-Friede et al., 2004).
 I.II. Collagen receptors
At sites of vascular injury, exposed collagen directly attaches to platelets through collagen 
receptors such as α2β1 and GpVI. This attachment is dependent on the native structure of 
collagen and is influence by the cations present in the media (Savage et al., 1999;Siljander and 
Lassila, 1999). These receptors mediate platelet adhesion at low shear stress. At sites of high 
shear stress, the initial interaction between VWF and GpIb-IX-V is a prerequisite to slow the 
platelets and allow the collagen receptors to interact with exposed collagen. The engagement of 
these receptors contributes to form stable platelet adhesion and subsequent thrombus growth.
 I.III. Integrin αIIbβ3
This receptor is the most abundant glycoprotein receptor expressed on platelets at 
approximately 80,000 copies per platelet. The integrin αIIbβ3 is a Ca2+-dependent heterodimer 
composed of an αIIb subunit and a β3 subunit. αIIbβ3 has several interacting partners such 
as VWF, fibrinogen, fibronectin and vitronectin, and it can also bind prothrombin (Fig. 4) 
(Takaaki et al., 2002). The most important ligands mediating adhesion through this receptor are 
fibrinogen and VWF. While fibrinogen mediates platelet adhesion at low shear stresses, VWF 
is the main ligand mediating platelet adhesion under high shear stress condition (>30 d/cm²) 
(Savage et al., 1996). The interaction between αIIbβ3 and fibrinogen is irreversible; therefore, 
when platelets adhere to fibrinogen at low shear stress, the attachment is firm and platelets 
do not translocate or role onto the matrix (Savage et al., 1996). When platelets are exposed 
to a thrombogenic surface such as collagen or subendothelial matrix in the presence of high 
shear stress, the interaction between fibrinogen and αIIbβ3 is not sufficient to mediate platelet 
adhesion, because the strength of the bonds is not sufficient to withstand tensile dragging forces. 
Here also the VWF-GpIbα interaction is important to slow the platelets in order for αIIbβ3 to 
find its ligand and allow platelets to firmly adhere to the injured site (Savage et al., 1998).
 4.2.3. Effects of shear stress on platelet aggregation
Once a firm layer of platelets adheres to the site of endothelial denudation, it serves as a new 
surface and this ”platelet surface” recruits other platelets (platelet aggregation) to the site in 
order for the thrombus to growth and close the vessel. Platelet aggregation can also be elicited 
in the absence of a thrombogenic surface by exposing platelets to soluble agonist like thrombin 
or adenosine 5’-diphosphate (ADP), or to high levels of shear stress (>30 d/cm²). In 1975, 
Brown and colleagues first reported the direct effects of shear stress on platelets by using a 
cone-plate viscometer (Brown III, et al., 1975), and later a series of paper demonstrated that 
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shear stress elicits platelet responses that culminate in platelet aggregation and this aggregation 
is essentially mediated through two receptors and two ligands: GpIb-IX-V and αIIbβ3, and 
VWF and fibrinogen (Baumgartner et al., 1980;Moake et al., 1986;Peterson et al., 1987;Stel et 
al., 1985;Turitto and Weiss, 1980).
 I. Receptors involved in shear-induced platelet aggregation.
 I.I. Glycoprotein Ib-IX-V 
Most studies aimed at assessing the direct effects of shear stress on platelet aggregation have 
used rotational viscometers that are able to produce a constant and uniform shear force (Kroll et 
al., 1996). These studies have established that GpIb-IX-V interactions with VWF are essential 
mediators of platelet aggregation under conditions of high shear stress (>30 d/cm²) (Moake et 
al., 1986;Moake et al., 1988;Peterson et al., 1987). The recently reported crystal structures of 
GpIbα N-terminal domain; and GpIbα complex with the A1 domain of VWF show that these 
molecules interact at two places: one high affinity interaction and one low affinity interaction 
(Sadler, 2002;Huizinga et al., 2002;Uff et al., 2002). These reports suggest that shear stress 
modifies VWF relieving an inhibitory domain present in its amino-terminal A1 domain 
permitting the interaction with the amino-terminal domain of GpIbα. Simultaneously shear 
stress modifies the carboxy-terminal region of GpIbα forming a β-strand motif that aligns with 
a central β strand in the VWF-A1 domain forming a strong interaction. Many previous reports 
support the conclusion that shear stress affects GpIbα (Fredrickson et al., 1998;Peterson et al., 
1987) as well as VWF (Fredrickson et al., 1998;Siedlecki et al., 1996). Moreover mutations 
in GpIbα or VWF allow these molecules to interact more easily as in the case of platelet-type 
von Willebrand disease and von Willebrand disease type IIb (Lopez et al., 1998;Budde and 
Schneppenheim, 2001). In addition, ultralarge multimers of VWF bind spontaneously to GpIbα 
(Arya et al., 2002). Therefore, it is reasonable to conclude that shear stress affects both GpIbα 
and VWF; but the question of how shear stress induces the conformational changes remains 
unanswered.
 I.II. Integrin αIIbβ3 
While GpIb-IX-V receptor mediates platelet aggregation under high shear stress, the αIIbβ3 
receptor mediates platelet aggregation at all shear stresses and it does so by tethering platelets 
to each other through VWF and/or fibrinogen. Nevertheless, recent reports that mice deficient of 
VWF and fibrinogen are able to form a thrombus have raised the possibility that fibronectin also 
plays an important role in thrombus development (Ni et al., 2000;Ni et al., 2003). At this point, 
however, I will focus only on fibrinogen and VWF.
Under conditions of low shear stress (<15 d/cm²) fibrinogen is able to mediate platelet adhesion 
and aggregation independently of VWF (Ruggeri et al., 1999). On the other hand, if the shear 
stress increases fibrinogen becomes less important and platelet aggregation is solely dependent 
on VWF interactions with αIIbβ3 and GpIb-IX-V (Ikeda et al., 1991;Peterson et al., 1987). One 
has to keep in mind that the previous findings are based on experiments conducted in suspended 
platelets subjected to shear forces in the absence of a thrombogenic surface. When thrombus 
growth is induced in a flow chamber in the presence of collagen as the thrombogenic surface, 
thrombus growth is independent of fibrinogen; however, this thrombus is not stable, suggesting 
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that fibrinogen plays an important role, when blood flow is almost null and the shear forces 
decrease allowing the low rate fibrinogen-αIIbβ3 interactions to occur stabilizing the thrombus. 
These observations are supported by studies carried in mice deficient in fibrinogen, where 
arterial thrombus forms but it is unstable and embolization occurs (Ni et al., 2000).
 I.III. Role of ADP receptors
While GpIb-IX-V and αIIbβ3 are the main receptors mediating platelet aggregation, this is 
a complex phenomenon influenced by several substances present in the microenvironment 
surrounding the developing thrombus. Upon attachment, platelets get activated and secrete 
prothrombotic materials like VWF and ADP. Platelets express two receptors for ADP, P2Y
1
 and 
P2Y
12
 (Fig. 6 A). Studies have convincingly shown that stimulation of P2Y
1
 leads to platelet 
shape change, while stimulating P2Y
12
 promotes platelet aggregation (Eckly et al., 2001), 
and both P2Y
1
 and P2Y
12
 play an important role in shear stress-induced platelet aggregation 
(Mazzucato et al., 2004;Turner et al., 2001). Moreover, P2Y
12
 blockade has had a remarkable 
positive impact on the treatment of patients at high risk of suffering from coronary or cerebral 
arterial thrombosis (Hirsh and Bhatt, 2004).
 4.2.4. Shear stress-induced signaling events
In the previous section, extracellular events leading to platelet adhesion and aggregation under 
conditions of shear stress were discussed. These events, however, are governed by a complex 
array of intracellular signals. It is believed that shear forces drive the initial VWF-GpIbα 
interaction, but once this interaction takes place a series of signaling events foster platelet 
secretion and the activation of integrin receptors.
 I. Glycoprotein Ib-IX-V and αIIbβ3 signaling
A long-stand debate has roiled over the question of GpIb-IX-V signaling, since this receptor 
is not coupled to heterotrimeric G proteins and does not possess kinase activity (Canobbio et 
al., 2004;Lopez, 1994). The earliest reports showed that shear stress-induced VWF-GpIb-IX-
V interactions resulted in a rapid increase in intracellular Ca2+ associated with protein kinase 
C (PKC) activation, the phosphorylation of pleckstrin and the activation of tyrosine kinases 
(Kroll et al., 1993;Chow et al., 1992;Razdan et al., 1994). Although these reports appeared 
more than 10 years ago, mechanisms of GpIb-IX-V signaling are still uncertain. Reports have 
suggested direct signaling of GpIb-IX-V through its cytoplasmic tail and associated molecules 
(Fig. 4) (Christodoulides et al., 2001;Feng et al., 2003;Gu et al., 1999;Yuan et al., 1999). 
Others have suggested that signaling through GpIb-IX-V depends on its association with 
Fc receptors (Sullam et al., 1998;Canobbio et al., 2001;Wu et al., 2001;Falati et al., 1999). 
A recent report, in static conditions, demonstrates that GpIb-IX-V induces the activation 
of αIIbβ3 independently of other receptors through signals that include Ca2+ increase, Src 
activation and the activation of PKC and PI3K (Kasirer-Friede et al., 2004) indicating that 
the original observations were correct (Fig. 5). The “weak” signals generated by GpIb-IX-V 
serve to activate αIIbβ3. Activated αIIbβ3 binds ligand and generates outside-in signaling. 
This probably occurs because the intracytoplasmic tails of αIIb and β3 interact with several 
proteins that form signaling complexes (Fig. 4). αIIbβ3 interacts with tyrosine kinases like Src 
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and Syk, adapter proteins like Shc and Grb2 and cytoskeletal proteins like talin, filamin and 
α-actinin (Buensuceso et al., 2004;Takaaki et al., 2002). Signaling events triggered by these 
complexes lead to the activation of phospholipase C (PLC) γ2 leading to Ca2+ oscillations, the 
activation of tyrosine kinases like Src, focal adhesion kinase (FAK) and Syk and the production 
of D3-phosphoinositides by activated PI3K (Fig. 5). These responses lead to cytoskeletal 
reorganization and substantiate the affinity/avidity of αIIbβ3 for its ligands (Shattil et al., 
1998;Takaaki et al., 2002).
 II. Contribution of ADP      
Signals downstream of GpIb-IX-V and αIIbβ3 cause platelet secretion of several pro-
aggregatory molecules like VWF, fibrinogen, ADP and Thromboxane A2 (TxA2). While the 
amount of TxA2 produced is not sufficient to enhance shear stress-induced platelet aggregation, 
released ADP is essential for platelet aggregation induced by shear stress (Moake et al., 
1988;Sun et al., 2004). The ADP receptors P2Y
1
 and P2Y
12
 are coupled to heterotrimeric Gq 
Figure 5. Signaling events downstream of GpIb-IX-V and αΙIbβ3. VWF binding to GpIbα activates 
several molecules that signal the activation (inside-out signaling) of αIIbβ3. Activated αIIbβ3 binds ligand 
and triggers outside-in signals that drive platelet responses like shape change and secretion. Molecules 
inside stars indicate activation.
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and Gi proteins, respectively (Fig. 6 A) (Woulfe et al., 2002).  Gq proteins activate PLCβ and 
Gi proteins inhibit the synthesis of cAMP and activate PI3Ks (Fig. 6 B), the details on the 
signaling events triggered by these receptors are discussed in section 4.3.3 II.
 III. Role of phosphatidylinositol 3-kinase
Although the activation of PI3K by different platelet agonists has been convincingly shown, the 
activation of PI3K in shear stress-induced platelet aggregation is less certain. In 1994, Jackson 
et al reported the activation of PI3K downstream on GpIb-IX-V, in platelets stimulated with 
VWF plus ristocetin (Jackson et al., 1994). Recently, two different groups suggested a role for 
PI3K in the activation of αIIbβ3 downstream of GpIb-IX-V (Kasirer-Friede et al., 2004;Yap et 
al., 2002). Moreover, recent reports of PI3K knockout mice confer these mice protection for the 
development of thromboembolic events (Hirsch et al., 2001). Even as the relevance of PI3K 
downstream of GpIb-IX-V in shear stress-induced platelet activation is becoming apparent, 
there are no reports of the production of D3-phosphoinositides in platelets activated by shear 
stress and mechanisms by which PI3Ks are activated in platelets stimulated by shear stress are 
completely unknown.
4.3. Thrombin-induced platelet responses
Thrombin is a serine protease that regulates several physiological responses in the vascular 
system, like the cleavage of fibrinogen to generate insoluble fibrin. Thrombin also regulates 
cellular activities mainly by the cleavage of a family of receptors termed protease-activated 
receptors. 
 4.3.1. Thrombin generation
Being thrombin a molecule that regulates several physiological responses, it is no surprise that 
its generation is tightly controlled. Prothrombin, the precursor of thrombin, circulates freely in 
plasma at concentrations ∼100 µg/ml. In order for prothrombin to be converted to thrombin the 
activation of certain coagulation factors such as factor VII, factor V and factor X is required. 
These activated factors form complexes on the membranes of activated platelets expressing 
positively charged phospholipids (mainly phosphatidylserine) and, in the presence of Ca+, 
activated factors Va and Xa convert prothrombin into thrombin (Monroe et al., 2002).
 4.3.2. Thrombin receptors in platelets
For many years it was known that thrombin caused platelet aggregation, but the receptor(s) 
responsible for this remained elusive. In the beginning of the 1990’s a receptor with the 
particularity that upon cleavage of its N-terminal extracellular domain was able to interact 
with itself through its newly exposed N-terminal was described and a new family of receptors 
was created: protease-activated receptors (PARs) (Vu et al., 1991). The first receptor identified 
was termed PAR1 and was immediately identified as ”the receptor” responsible for thrombin-
induced responses in platelets, but soon it became clear that platelets express other thrombin 
receptor(s) (Connolly et al., 1996). Presently, three receptors of this family are known to be 
present in human platelets: PAR1, PAR3 and PAR4 (Kahn et al., 1999;Schmidt et al., 1998). 
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While the roles of PAR1 and PAR4 in mediating platelet responses are established; PAR3 
expression in human platelets is minimal and its contribution to platelet responses uncertain 
(Kahn et al., 1999). In platelets, besides cleaving PARs, thrombin also cleaves GpV and 
interacts with GpIbα, both members of the GpIb-IX-V complex (Harmon and Jamieson, 
1986;Jamieson and Okumura, 1978;Knupp and White, 1984).
 I. Protease-activated receptors
PAR1 is the predominant thrombin receptor mediating human platelet function. PAR1 is cleaved 
by picomolar concentrations of thrombin; in contrast, PAR4 cleavage requires 10 to 100-fold 
higher concentrations. The difference in sensitivity is due to a hirudin-like domain present in the 
exodomain of PAR1 (and PAR3) but not in PAR4 (Coughlin, 2001). This sequence facilitates 
an interaction with thrombin that enhances the receptor cleavage. Another important difference 
between these two receptors is that cleaved PAR1 is rapidly shutoff by phosphorylation, after 
which, it is internalized and directed to lysosomes where it is mostly degraded (Hoxie et al., 
1993;Shapiro et al., 1996). In contrast, cleaved PAR4 is down-regulated much more slowly and 
therefore generates long-lasting signals (Shapiro et al., 2000). Furthermore, signals generated 
by PAR4 seem to be more robust than those ones generated by PAR1 (Shapiro et al., 2000).
 II. Glycoprotein Ib-IX-V
Recent studies found that GpIbα interacts with two molecules of thrombin (Celikel et al., 
2003;Dumas et al., 2003). Thrombin also cleaves GpV from the GpIb-IX-V complex. 
The lack of GpV in mice enhances platelet responses to thrombin and interestingly these 
platelets react strongly to inactivated-thrombin downstream of GpIbα (Ramakrishnan et al., 
1999;Ramakrishnan et al., 2001). Moreover, a recent report found that immobilized inactivated-
thrombin (by binding of its active catalytic site to PPACK) induces platelet signaling and 
aggregation downstream of GpIbα (Adam et al., 2003). Finally, thrombin-GpIbα interaction 
also facilitates thrombin cleavage of PAR1 (De Candia et al., 2001). 
 4.3.3. Signaling through G-protein coupled receptors
Platelets express several receptors that belong to the G-protein coupled receptors (GPCRs) 
family. These receptors generate a wide range of intracellular responses including suppression 
of cAMP synthesis, phosphoinositide hydrolysis, protein phosphorylation and increases in 
cytosolic free Ca2+. These signaling events direct platelet functions like secretion, shape change, 
integrin activation and aggregation. Among the platelet receptors that belong to the GPCR 
family are the thrombin and ADP receptors. 
 I. Protease-activated receptors
Signals generated by PAR1 and PAR4 are similar since both receptors couple Gq and G
12/13
 
family members of heterotrimeric G-proteins (Fig. 6 A) (Hung et al., 1992;Offermanns et 
al., 1994). Upon receptor activation the heterotrimeric Gq dissociates into Gqα and Gqβγ; 
dissociated Gqα activates PLCβ. Activated PLCβ hydrolyzes phosphatidylinositol 4,5-
bisphosphate (PI(4,5)P
2
) into inositol 1,4,5 trisphosphate (1,4,5-IP
3
) and diacylglycerol. 1,4,5-
IP
3
 is responsible for a rapid increase in intracellular Ca2+ resulting in the phosphorylation/
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activation of downstream effectors (Offermanns, 2003). One such effector is myosin light chain 
(MLC), which directs platelet cytoskeletal reorganization – shape change and secretion (Fig. 
6 B). MLC is phosphorylated by a Ca2+-dependent calmodulin MLC-kinase (MLCK) and is 
downregulated by a myosin phosphatase, which is in turn phosphorylated/downregulated by 
Rho (downstream of G
12/13
) (Offermanns, 2000;Offermanns, 2003). Diacylglycerol activates 
several PKC isoforms, which in turn phosphorylate several ser/thr kinases leading platelets to 
secrete and regulate the activation-expression of αIIbβ3 to support aggregation (Fig. 6 B) (Hers 
et al., 1998). How PKC is able to mediate platelet secretion is not well understood, but many 
studies have shown that PKC activation and an increase in intracellular Ca2+ act synergistically 
to induce full platelet secretion (Kaibuchi et al., 1983;Walker and Watson, 1993;Siess and 
Lapetina, 1988). PARs also couple to G
12/13
 family members, which activate members of the 
Rho family of protein kinases. Recently, several guanosine nucleotide exchange factor (GEF), 
Figure 6. (A) Thrombin and ADP receptors in human platelets and their associated heterot-
rimeric G proteins. (B) Signaling events downstream of heterotrimeric G proteins. Molecules 
inside stars indicate activation.
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p115RhoGEF, PDZ-RhoGEF and leukemia-associated RhoGEF (LARG), have been recognized 
as binding partners of Gq
12/13
 proteins (Suzuki et al., 2003;Fukuhara et al., 1999;Hart et al., 
1998). Upon stimulation, these GEF proteins confer GTPase activity to Rho. Activated Rho 
signals platelet shape change and secretion by up-regulating the phosphorylation of myosin 
light chain as described above (Fig. 6 B). G
12/13
 proteins interact with several other proteins like 
Bruton’s tyrosine kinase (Btk), Ras GTPase-activating protein, Gap1m, radixin and cadherin 
(Offermanns, 2003), suggesting that through these interactions G
12/13
 proteins are able to 
mediate several intracellular responses.
II. ADP receptors
The ADP receptors P2Y
1
 and P2Y
12
 also belong to the GPCR family. P2Y
1
 is coupled to Gq 
proteins (Fig. 6 A) and its stimulation elicits similar events as those described above for Gq 
proteins coupled to PARs. P2Y
12
 associates with Gi proteins and its activation results in the 
dissociation of Giα and Giβγ subunits. Giα inhibits adenylyl cyclase activity thereby hampering 
the synthesis of cAMP, which is a platelet inhibitor (Offermanns, 2000) and Giβγ activates 
PI3Kγ and possibly PI3K class IA (PI3K-IA) (Fig. 6 B). Giβγ promote PLCβ activation, 
especially the PLCβ2 and PLCβ3 isoforms, but the implication of this in platelet function is 
uncertain (Banno et al., 1998;Offermanns, 2003). Moreover, There is a growing list of proteins 
that interact with Giβγ, suggesting that Giβγ proteins regulate many yet undiscovered cellular 
functions (Cabrera-Vera et al., 2003). Signals generated downstream of ADP receptors are 
especially important when platelets are stimulated with low thrombin concentrations, or through 
the PAR1 receptor. ADP scavengers or P2Y
12
 blockade reverse aggregation induced by low 
dose-thrombin or through the PAR1 receptor (Kovacsovics et al., 1995;Trumel et al., 1999).
 
 III. G-protein knockouts – effects on platelet signaling
The key role of Gqα proteins downstream of thrombin was clearly shown by Offermanns et al 
who found null responses to thrombin stimulation in mice platelets deficient of Gqα. These mice 
have prolonged bleeding times and are protected against thromboembolism induced by collagen 
and adrenaline. Although; mouse platelets do not express PAR1 instead express high levels of 
PAR3, the results from the knockout mouse together with previous studies in human platelets 
strongly suggest that Gq proteins are essential mediators of thrombin-induced platelet responses 
(Offermanns et al., 1997). Recently, the same group reported a new platelet phenotype that 
lacks the G
12
α and/or G
13
α proteins. This study convincingly shows that G
13
, but not G
12
 is the 
other essential G protein coupled to the thrombin receptors. In vitro, these platelets present 
deficient activation of Rho together with severe defects in shape change and aggregation 
when stimulated by thrombin or TxA2. Moreover, mice lacking G
13
α have prolonged bleeding 
times and are unable to form thrombus after arterial vascular injury (Moers et al., 2003). Gi
2
α 
knockout mice do not present any obvious hemostatic abnormality. However, in vitro analyses 
place this Gi protein subtype as the one that inhibits cAMP production downstream of P2Y
12
. 
Furthermore, aggregation induced by ADP and low concentrations of thrombin is also impaired 
in these platelets (Jantzen et al., 2001;Woulfe et al., 2002). Deletion of Gzα confirms that this 
is the Gi subtype coupled to the adrenaline receptor; these platelets failed to inhibit cAMP 
production when stimulated by adrenaline (Yang et al., 2000). Deletion of Gi
3
α, G
11
α, G
15
α or 
G
12
α had no apparent effect on platelet phenotypes (Woulfe et al., 2002).
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  4.3.3. Role of phosphatidylinositol 3-kinase
Soon after the discovery of D3-phosphoinositides, reports emerged that thrombin-stimulated 
platelets accumulated this kind of lipids (Kucera and Rittenhouse, 1990;Sultan et al., 1990). 
Subsequently, important platelet responses downstream of thrombin stimulation have been 
attributed to PI3K signaling. Inhibition of PI3K causes disaggregation in platelets stimulated 
with low thrombin concentration, which is the result of αIIbβ3 deactivation (Kovacsovics et al., 
1995). PAR1 stimulation induces pleckstrin–a major PKC substrate–phosphorylation, in a PI3K 
dependent manner (Toker et al., 1995) and pleckstrin regulates actin assembly (Lemmon et al., 
2002;Ma and Abrams, 1999). PI3K products uncap actin filaments and prevent actin filament 
severing and capping, thereby promoting actin assembly triggered by suboptimal stimulation of 
the PAR1, although PI3K products are not needed if PAR1 is fully stimulated (Hartwig et al., 
1995). Thrombin-induced PI3K activation also results in Akt phosphorylation (Banfic et al., 
1998a), and recent reports from Akt knockout mice show an important role for Akt signaling 
downstream of thrombin (Chen et al., 2004;Woulfe et al., 2004).
 I. Thrombin signaling PI3K activation 
Activation of different types of PI3Ks in thrombin-stimulated platelets occurs. Gβγ proteins 
activate PI3Kγ, but the mechanism(s) leading to PI3K-IA activation remain vague. Zhang et al 
reported that PI3K-IA activation is downstream of Rho, which co-immunoprecipitates with the 
p85 subunit, although no direct association between Rho and PI3K-IA has been found (Zhang 
et al., 1993). A role for tyrosine-phosphorylated proteins in the activation of PI3K-IA has also 
been suggested (Guinebault et al., 1993), but the identity of those proteins remains unknown.
4.4. Phosphatidylinositol 3-kinase
The phosphorylation at the D3-hydroxy-group of the inositol headgroup ring of 
phosphoinositides (Fig. 7) was first published in 1988 (Traynor-Kaplan et al., 1988;Whitman et 
al., 1988) initiating an immense exploration on the biological responses triggered by this new 
class of lipids. The identification of these phosphoinositides was prompted by the observations 
CH
O
C
O
C
CH2
CH2
O
PO
OH
OH
HO
HO OH
H
H
H
H
H
1
2
6
3
5
4
O
O-
O
O
PI3K
Phosphatidylinositol
Figure 7. Chemical structure of phosphatidyli-
nositol showing the D-3 position phosphorylated by 
phosphatidylinositol 3-kinase (PI3K).
of phosphoinositide kinase activity 
associated with polyoma middle T 
antigen, pp60 (v-Src) and pp68 (v-Ros), 
(Macara et al., 1984;Whitman et al., 
1985). These pioneering studies triggered 
vast research concentrated on the 
characterization of these new enzymes 
capable of phosphorylating the D-3 
position of the inositol ring, and included 
the cloning of the p85 regulatory 
subunits of phosphatidylinositol 3-kinase 
(PI3K) (Skolnik et al., 1991;Otsu et al., 
1991;Escobedo et al., 1991) and the 
characterization of its p110-associated 
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subunits (Hiles et al., 1992;Hu et al., 1993). After these initial discoveries, several other PI3Ks 
have been characterized and the family of PI3Ks has been divided into three subclasses.
 
4.4.1. The PI3K family
PI3Ks can be divided into three subtypes (Fig. 8) according to their ability to phosphorylate 
different kinds of phosphoinositides at the D-3 position.
I. PI3K class I
PI3K class I phosphorylates phosphatidylinositol (PI), phosphatidylinositol 4-phosphate 
(PI(4)P), and phosphatidylinositol (4,5)-bisphosphate (PI(4,5)P
2
), the last one being the 
preferred substrate (Fruman et al., 1998;Wymann and Pirola, 1998). PI3K class I family 
members have a p110 catalytic subunit, and those p110 subunits that associate with regulatory 
subunits that contain Src homology (SH) 2 domains are classified as PI3K class IA (PI3K-IA).
PI3K-IA comprises several regulatory isoforms (p85α, p85β, p50α, p55α and p55γ) of which 
p85 is the prototype. The p85 subunit contains one SH3 domain, which binds to proline rich 
sequences; two proline rich regions, which give this enzyme the capacity to bind proteins 
containing SH3 domains; a Bcr homology (BH) region, which interacts with proteins containing 
GTPase activity such as Cdc42 and Rac. p85 also contains SH2 domains, one N-terminal 
and one C-terminal, these SH2 domains bind tyrosine-phosphorylated proteins. The two SH2 
domains are connected by an inter-SH2 domain, which is the site where the tight interaction 
with the p110 catalytic subunit takes place (Fruman et al., 1998;Wymann and Pirola, 1998). 
There are three P110 catalytic subunits of PI3K-IA: p110α, p110β and p110δ. Intriguingly, 
besides phosphorylating lipids, all p110 catalytic subunits posses intrinsic serine protease 
activity, a function of which little is known (Foukas and Shepherd, 2004).
The only member of the phosphatidylinositol 3-kinase class IB family is termed PI3Kγ. This 
enzyme is present only in mammals and is preferentially expressed in leukocytes (Koyasu, 
2003). The catalytic subunit p110γ of this enzyme interacts with a different regulatory subunit 
termed p101. This enzyme is distinct from the PI3K-IA in that it is not activated by tyrosine-
phosphorylated proteins, but rather by Gβγ subunits of heterotrimeric G proteins.
 II. PI3K class II and III
The class II PI3K is comprised of three members: PI3K-C2α and PI3K-C2β are expressed 
ubiquitously in mammals, while the third member, PI3K-Cγ is expressed primarily in 
hepatocytes. PI3K class II members phosphorylate PI and PI(4)P exclusively. The class III PI3K 
exclusively phosphorylates PI and includes only one member, the Vps34p. This enzyme was the 
first PI3K with an assigned function; it directs vacuolar protein sorting and vacuole segregation 
in yeast (Herman and Emr, 1990;Schu et al., 1993).
 4.4.2. Mechanisms of activation of PI3K
 I. PI3K class IA
The multiple array of protein-binding domains present in the p85 regulatory subunit of PI3K-
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IA confers stupendous versatility to this enzyme to bind multiple proteins at the same time; 
these partners combine to fine-tune the activity of PI3K-IA (Wymann and Pirola, 1998). The 
classical mechanism of activation of the PI3K-IA is its association with tyrosine-phosphorylated 
proteins, this is in fact the way the p85 subunit of this class of enzymes was first detected, in 
immunoprecipitations of tyrosine-phosphorylated proteins (Kaplan et al., 1987). Several other 
mechanisms to regulate PI3K-IA activity have been described and four are well documented.
1. Targeting its p85 SH2 domains (Fig. 8) to pYXXM (where pY is phosphorylated 
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Figure 8. Structural characteristics of the phosphatidylinositol 3-kinase (PI3K) family. Three classes 
of PI3K have been described. Most catalytic subunits share four domains: Catalytic domain; Lipid kinase 
domain (PIK) that is present in lipid kinases but not protein kinases; C2 domain that binds phospholipids 
and may recruit PI3K to the membrane; and a Ras binding domain (Ras-B), which interacts with GTP-
loaded Ras. The p110γ catalytic subunit also possesses two Gβγ binding domains (βγ), which serve to acti-
vate this enzyme.   The regulatory subunits for the phosphatidylinositol 3-kinase class IA contain proline-
rich regions; two SH2 domains that bind tyrosine phosphorylated proteins and activate the enzyme. The 
SH2 domains are link by an inter-SH2 domain, which is the point of interaction with the catalytic subunit. 
In addition, p85 subunits have an SH3 domain that interacts with proline-rich regions and a BH domain 
that interacts with GTPases. Figure adapted from Wymann MP, and Pirola L (Wymann and Pirola, 1998), 
Fruman DA at al (Fruman et al., 1998) and Koyasu S (Koyasu, 2003).
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tyrosine, M is methionine and X represents any amino acid) motifs present in tyrosine kinase 
receptors, such as the insulin receptor (Ruderman et al., 1990;Van Horn et al., 1994). Trough 
this binding PI3K-IA translocates to the plasma membrane and gains access to substrate. This 
translocation is considered sufficient to render activity to PI3K-IA (Jimenez et al., 1998;Klippel 
et al., 1996), although some contradictory data exist (Chan et al., 2002). PI3K-IA also 
associates with tyrosine-phosphorylated proteins that are not-receptors, but function as adaptors 
bridging PI3K-IA with membrane-associated proteins co-localizing the enzyme with its 
substrate. This is the more common way to activate PI3K-IA and a long list of adaptor-proteins 
exists including Syk, Src and FAK. The association with tyrosine kinases not only brings PI3K-
IA close to the substrate but simultaneously increases dramatically the activity on the enzyme 
(Myers, Jr. et al., 1992;Rordorf-Nikolic et al., 1995).
2. Binding of proteins containing SH3 domains (from the Src-family) to the proline-
rich regions in the p85 subunit (Fig. 8) activates PI3K-IA. The binding of the SH3 domains 
of Fyn and Lyn increases the enzymatic activity of PI3K-IA by 5 to 7 fold, and this activity is 
block by peptides containing the proline-rich region 1 of PI3K-IA (Pleiman et al., 1994).
3. Conversely, PI3K-IA is activated by the binding of its p85 SH3 domain (Fig. 8) 
to proline rich regions of diverse proteins such as Shc, Cbl, dynamin (Wymann and Pirola, 
1998;Hunter et al., 1997).
4. Association of its p110 catalytic subunit with GTP loaded Ras (Fig. 8) activates 
PI3K-IA; although, both PI3K-IA and PI3Kγ bind Ras only the PI3K-IA is activated by it 
(Rodriguez-Viciana et al., 1994). The amino acid Lys227 in the p110 is crucial for Ras binding 
and mutation of this amino acid for Glu increases PI3K-IA activity by fourfold, suggesting a 
conformational change that could mimic the binding of Ras (Rodriguez-Viciana et al., 1996).
Other debatable mechanisms by which PI3K-IA can be regulated are reported; such as the 
phosphorylation of the p85 subunit by the p110 catalytic subunit, the tyrosine phosphorylation 
of the p85 subunit by other kinases, p110β subunit association with Gβγ subunits (Wymann 
and Pirola, 1998), and association with small GTPases (Rac, Ras, Cdc42) in conjunction with 
phosphorylation of the p85 subunit (Chan et al., 2002).
 II. PI3K class IB
The only representative of this kind of enzymes is PI3Kγ. PI3Kγ is activated downstream of 
G protein-coupled receptors, which upon activation release their heterotrimeric G proteins 
dissociating into Gα and Gβγ subunits, the released Gβγ interacts with p110γ catalytic subunit 
and activates it (Fig. 8).
 III. PI3K class II and III
PI3K class II are activated downstream of integrin, chemokine, and growth factor receptors, but 
its mechanisms of activation remain obscure. PI3K class III is constitutively active in vitro, and 
since the levels of phosphatidylinositol 3-phosphate  (PI(3)P) remain fairly constant in cells, 
PI3K class III appears not to be acutely activated by cellular stimuli (Vanhaesebroeck et al., 
2001).
 4.4.3. PI3K signaling through D3-phosphoinositides
Targets of D3-phosphoinositides can be divided in those activated by PI(3)P, 
28
REVIEW OF THE LITERATURE
29
REVIEW OF THE LITERATURE
phosphatidylinositol 3,4-bisphosphate (PI(3,4)P
2
) and/or phosphatidylinositol 3,4,5-
trisphosphate (PI(3,4,5)P
3
). PI(3)P mediates an essential function in vesicular trafficking in 
yeast, and its mammalian counterpart probably plays a similar role directing vesicular transport 
(Simonsen et al., 2001). PI(3)P binds to various proteins containing FYVE finger domains, 
which are named after the first four proteins where they were recognized: Fab1p, YOTB, Vac1p 
and Early endosome antigen 1. Although, PI3K class III may be the only enzyme that produces 
PI(3)P in yeast, it is presently unclear which is/are the enzyme(s) that mediate PI(3)P production 
in mammals, although reports suggest that it could also be a class III PI3K.
PI(3,4)P
2
 and PI(3,4,5)P
3
 mediate numerous cellular responses such as cytoskeletal 
rearrangement, metabolism, immune-mediated responses, fetal development, cellular growth, 
survival and apoptosis . Due to the numerous cellular responses that PI(3,4)P
2
 and PI(3,4,5)P
3
 
mediate, they have to regulate the activity of a large number of proteins, some of which are 
discussed below. 
 I. Effectors of PI(3,4)P
2
 and PI(3,4,5)P
3
Guanosine nucleotide exchange factors and GTPases. GEFs catalyze the conversion of 
small GTPases from the inactive GDP-binding form to the active GTP-binding form. GEFs 
contain pleckstrin homology (PH) domain(s) that bind phosphoinositides and this binding 
is believed to mediate their activity. For example, the Rac-GEF activity of Vav is stimulated 
by phosphoinositides (Han et al., 1998). Besides regulating GEFs, D3-phosphoinositides 
directly regulate GTPases. For example, members of the Rho family of GTPases are important 
mediators of cytoskeletal organization by mediating actin assembly. Phosphoinositides regulate 
Rho GTPases by creating a lipid gradient which localize these enzymes to the membrane in 
the leading edge of a moving cell (Wang et al., 2002). Other family of GTPases is the ADP 
ribosylation factors (Arfs). D3-phosphoinositides mediate Arfs function, which is to regulate 
membrane trafficking and probably cytoskeletal reorganization (Vanhaesebroeck et al., 2001). 
Protein kinase C and Phospholipase C. Several laboratories have reported the phosphorylation/
activation of several PKC enzymes via D3-phosphoinositides in vitro (Derman et al., 1997). 
The means by which D3-phosphoinositides regulate PKC activation are partially known. 
Phosphoinositide-dependent kinase 1 (PDK-1) phosphorylates several PKCs; however, PDK-1 
phosphorylates PKCs in a phosphoinositide-dependent and independent manner, confusing the 
picture of how the regulation of PKC downstream of PI3K is being achieved. Other enzymes 
regulated by D3-phosphoinositides are PLC. PLCγ activity is enhanced by its direct and indirect 
binding to D3-phosphoinositides via Btk (Falasca et al., 1998;Bae et al., 1998).
p70 ribosomal S6-kinase (p70S6k). This enzyme was the first effector of PI3K described 
(Cheatham et al., 1994;Chung et al., 1994). p70S6k has at least 8 phosphorylation sites, 
and mutations at any of these sites impair its kinase activity indicating that this enzyme is 
regulated by several mechanisms. One initial step in the activation of p70S6k is downstream of 
mitogen-activated protein kinases (MAPK), after this p70S6k is phosphorylated downstream 
of PI3K and the target of rapamycin (TOR) protein pathways (Toker, 2000). Also, PDK-1 
appears to play an important role downstream of PI3K in the regulation of p70S6k (Pullen et 
al., 1998;Alessi et al., 1998). p70S6k phosphorylates the 40 S ribosomal protein S, thereby 
regulating the translation of hundreds of proteins (Toker, 2000;Vanhaesebroeck et al., 2001).
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Protein tyrosine kinases. The Tec-family of tyrosine kinases is regulated downstream of PI3K. 
Btk, a member of the Tec-family, is recruited to the plasma membrane by D3-phosphoinositides, 
where it is phosphorylated by the Src family of tyrosine kinases and autophosphorylation. 
Activated Btk phosphorylates PLCγ and plays an essential role in lymphocyte development 
and function (Okkenhaug and Vanhaesebroeck, 2003a). In addition to the role of PI3K in Btk 
activation, multiple other tasks have been attributed to PI3Ks in lymphocyte function (Fruman, 
2004;Okkenhaug and Vanhaesebroeck, 2003b).
MAPK. Interestingly MAPK are few of the enzymes that are known to be regulated by the ser/
thr kinase activity of PI3K (Bondeva et al., 1998). Furthermore, MAPK can also be regulated 
through the activation of PKCζ downstream of PI3K.
 I.I. Regulation of Akt  through PDK-1
A particularly well-characterized target of PI3K is Akt, thereby, it has been used in several 
studies as a marker of PI3K activity and recent studies suggest a role for Akt in platelet function 
(Chen et al., 2004;Woulfe et al., 2004). Akt was first identified and termed RAC (related to 
the A and C kinases) because of the similitude of its kinase domains (Jones et al., 1991). In 
the same year another group cloned the same molecule and named it protein kinase B (PKB), 
because of its similarity to PKC and PKA (Coffer and Woodgett, 1991). A third group found 
that PKB was the cellular homologous of the v-Akt oncogene and it was thereafter termed Akt 
(Bellacosa et al., 1991). Three isoforms of Akt have been found: Akt1 (PKBα) Akt2 (PKBβ) 
and Akt3 (PKBγ).  Akt is a serine and threonine kinase that it order to be fully active requires 
to be phosphorylated at Ser473 and Thr308. Phosphorylation at Thr308 is dependent on its 
proximity to the plasma membrane and the previous phosphorylation of the Ser473 residue, the 
phosphorylation at Thr308 is accomplished by PDK-1  (Scheid et al., 2002).
PDK-1 interacts with high affinity with PI(3,4,5)P
3
 and PI(3,4)P
2
, although its activity does not 
seem to depend on its association to D3-phosphoinositides, its activity depends on its proximity 
to the plasma membrane (Toker and Newton, 2000). PDK-1 regulates several cellular functions 
by phosphorylating multiple substrates in a phosphoinositide-dependent and independent 
manner. PDK-1 phosphorylates Akt at Thr308 in a PI(3,4,5)P
3
 dependent manner, although the 
requirement for PI(3,4,5)P
3
 is at the level of the substrate rather than at the level of the enzyme 
(Scheid et al., 2002). In other words Akt needs to be associated to PI(3,4,5)P
3
 in order to be 
phosphorylated by PDK-1. Akt phosphorylation at Ser473 occurs close to the plasma membrane 
and is also PI3K dependent, but the enzyme that phosphorylates Akt at Ser473 is still uncertain 
(Hanada et al., 2004). Although autophosphorylation occurs and several enzymes phosphorylate 
Akt at Ser473 in vitro the physiological role of these is uncertain (Hanada et al., 2004).
Akt has more than 50 substrates, and a consensus target sequence is found in most of them 
RXRXXS/T, where the phosphorylation sites are S (serine) or T (threonine), R represents 
arginine and X represents any amino acid (Alessi et al., 1996;Obata et al., 2000). Owing to 
its multiple substrates, Akt regulates several important cellular responses and here only some 
examples are given.
Akt regulates glucose metabolism by phosphorylating and inactivating the glycogen synthase 
kinase-3 (GSK-3) (Cross et al., 1995).
Akt regulates apoptosis. Akt phosphorylates BAD (Bcl-2/Bcl-X antagonist) causing the 
30
REVIEW OF THE LITERATURE
31
REVIEW OF THE LITERATURE
dissociation of BAD from Bcl-2 and Bcl-X, which prevent apoptosis (del Peso et al., 1997).
Akt regulates the cell cycle. Akt phosphorylates P21(cip1/waf1) inhibiting its potential to arrest 
the cell cycle, promoting cell proliferation (Xia et al., 2004;Hanada et al., 2004).
Akt regulates vascular tone and angiogenesis. Akt phosphorylates the endothelial nitric oxide 
synthase (eNOS) upregulating its activity, and promoting the release of nitric oxide (NO), which 
is a potent vasodilator that also inhibits platelet responses. (Fulton et al., 1999).
 4.4.4. PI3K in platelets
The first reports that stimulated platelets accumulate D3-phosphoinositides were published 
in the beginning of the 1990’s (Kucera and Rittenhouse, 1990;Sultan et al., 1990). Since then 
PI3K activation has been implicated in several important platelet responses like platelet shape 
change and stabilization of platelet aggregation (Kovacsovics et al., 1995;Hartwig et al., 
1996;Hartwig et al., 1995;Jackson et al., 2004).
Platelets contain PI3K class IA, catalytic subunits p110α, p110β and p110δ; class IB, p110γ 
and class II, C2α (Zhang et al., 2002;Selheim et al., 2000b). Diverse stimuli such as thrombin, 
collagen and β-PMA trigger the accumulation of D3-phosphoinositides in platelets. The 
accumulation of D3-phosphoinositides downstream of thrombin and TxA2 is largely dependent 
on released ADP co-stimulation. On the other hand, the accumulation of D3-phosphoinositides 
downstream of collagen receptors is independent of ADP co-stimulation (Selheim et al., 1999). 
The discovery that PI3Kγ is activated by Gβγ subunits (Stoyanov et al., 1995;Stephens et al., 
1994) points towards PI3Kγ as the isoform being activated downstream of G-protein coupled 
receptors such as the ADP receptors. In addition, recent reports from knock out mouse models 
place PI3Kγ as an important effector of P2Y
12
; while, using the same approach, other studies 
place PI3K-IA as an important effector of collagen receptors (Hirsch et al., 2001;Watanabe et 
al., 2003)
In platelets, PI3K triggers a wide variety of responses like the phosphorylation of pleckstrin, 
the activation of PLCγ, Rap1b and Akt (Banfic et al., 1998b;Lova et al., 2003;Pasquet et 
al., 1999;Trumel et al., 1999). Through these and other effectors, PI3K regulates at least 
two important platelet responses, actin assembly to promote platelet shape change and the 
activation of αIIbβ3 to promote stable platelet aggregation (Hartwig et al., 1996;Jackson et al., 
2004;Kovacsovics et al., 1995;Trumel et al., 1999).
 I. Akt in platelets
Akt is a well recognized target of PI3K, and recent reports from knockout mice strongly 
support a modulatory role for Akt in platelet function (Chen et al., 2004;Woulfe et al., 2004).  
Human platelets express at least two isoforms of Akt, Akt1 and Akt2, of which Akt1 is the 
more abundant (Kroner et al., 2000). After the first report of Akt phosphorylation in platelets 
(Banfic et al., 1998b), many platelet agonists have been shown to elicit Akt phosphorylation/
activation, but the physiological role of Akt in human platelet activation is still uncertain. 
In vitro assays showed that Akt directs the phosphorylation of the β3 tail of integrin αIIbβ3, 
modulating its binding properties (van Willigen et al., 1996;Kirk et al., 2000;Lerea et al., 1999). 
Moreover, intraplatelet delivery of peptides containing the β3 region potentially phosphorylated 
by Akt inhibits thrombin-induced αIIbβ3 binding to fibrinogen and fibronectin (Hers et al., 
2000;Litjens et al., 2003).
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5. Aims of the study
 
Our group concentrated on unraveling the mechanisms of shear stress-induced platelet 
aggregation and previous observations from our group suggested a possible role for PI3K in 
regulating platelet responses triggered by shear stress. This motivated us to study PI3K in more 
detail; in doing this we wanted to answer the following aspects about PI3K in shear stress-
stimulated platelets (Fig. 9). 
• Is PI3K activated?
• Contribution of PI3K to shear stress-induced platelet aggregation?
• Mechanism(s) of activation of PI3K?
• Contribution of ADP to PI3K activation?
Subsequently, we knew that thrombin activated PI3K but reports had failed to address the 
mechanisms of how PI3K is activated. Hence we decided to study if a similar mechanism to 
that found in shear stress-stimulated platelets could be found in thrombin-stimulated platelets, 
in doing this we wanted to answer the following aspects about PI3K in thrombin-stimulated 
platelets (Fig. 10).
• Mechanism(s) of activation of PI3K?
• Contribution of ADP to PI3K activation?
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Figure 9. Aims part one. Shear stress-induced binding of VWF to GpIbα triggers signaling. Does shear 
stress induces PI3K activation? What are the mechanisms leading to the activation of PI3K? What is the 
contribution of secreted ADP to the activation of PI3K? What is the contribution of PI3K to platelet ag-
gregation induced by shear stress?
 Figure 10. Aims part two.  Thrombin activates PI3K and this activation is known to be dependent on 
protein tyrosine kinases (PTK) and largely dependent on secreted ADP binding to P2Y
12
, which activates 
PI3Kγ. We tried to complete the scheme by identifying the PTKs that activate PI3K-IA? And study the 
involvement of the ADP receptors in the activation of PI3K-IA?    (?) Highlights activation pathways or 
molecules that are not clearly defined and were the focus of our study. 
Shape change
PI3K-IA PI3K�
?
PtdIns (3,4,5)P3
PtdIns (3,4)P2
�IIb�3
Shear-induced
GpIb�-VWF binding
?
? ?
VWF
P2Y12P2Y
1
?
?
?
Secreted
ADP
Secreted
ADP
Shape change
P2Y
12
Gi2
Thrombin
G��
PI3K-IAPI3K�
?
PtdIns (3,4,5)P3
PtdIns (3,4)P2
Akt PDK
Activated �IIb�3
?
P2Y1
?
PAR
Gq G12/13
PTK? Rho Gq
Secreted
ADP
Secreted
ADP
34
METHODS
35
METHODS
6. Methods
 6.1. Preparation of washed platelets
Venous blood was obtained from healthy volunteer donors who denied taking any medication 
for at least two weeks prior to donation. Blood was collected via a 19G needle, to minimize 
platelet activation, into 15% acid-citrate-dextrose. Blood was centrifuged at 270g at 24ºC for 
15 min. Platelet rich plasma (PRP) was collected and treated with phosphocreatine (5 mM) and 
creatine phosphokinase (25 U/ml). PRP was centrifuged at 1200g at 24ºC for 15 min; pelleted 
platelets were suspended in Tyrodes buffer (138 mM sodium chloride, 2.9 mM potassium 
chloride, 12 mM sodium bicarbonate, 0.36 mM sodium phosphate and 5.5 mM glucose, pH 6.5) 
containing phosphocreatine and creatine phosphokinase and then centrifuged at 1200g at 24ºC 
for 10 min. Washed platelets were finally suspended in ”JNL” buffer containing 6 mM glucose, 
130 mM NaCl, 9 mM NaHCO3, 10 mM Sodium citrate, 10 mM Tris base, 3 mM KCl, 2mM 
Hepes and 0.9 mM MgCl
2
, pH 7.35 to which 1 mM of CaCl
2
 was added.  In all experiments, 
unless stated, the final platelet concentration was 3 x 108 platelets/ml.
 6.1.1. Platelet labeling with 32P
For analysis of phospholipids, platelets were incubated with 2 mCi/ml of [32P]orthophosphate 
at 37ºC for 1 hour in Tyrodes buffer devoid of sodium phosphate, washed in Tyrodes buffer and 
suspended in JNL buffer.
 6.2. Platelet stimulation
 6.2.1. Shear stress system
To expose platelets to shear stress we used a cone-plate viscometer (Fig. 3). This viscometer 
consists of one flat surface (lower plate) and the upper surface has a subtle angle from the center 
to the edge of the plate (cone plate). This device can generate a constant and uniform shear 
stress for prolonged periods of time (Kroll et al., 1996), in our experiments we subjected human 
platelets to 120 dynes/cm², we chose this high level of shear stress to mimic the pathological 
shear stress that can be found in stenotic-diseased arteries. Platelets were exposed to shear stress 
for different times at 24°C. 5 µl of the sheared platelet suspension was fixed in 500 µl of 1% 
paraformaldehyde and aggregation measured by flow cytometry. By this method we measure 
the disappearance of single platelets, when platelets aggregate the number of single platelets 
decreases and a calculation can be made comparing the number of single platelets before and 
after shear stress and the decrease in the number of single platelets corresponds to platelet 
aggregation expressed in percentage.
 6.2.2. Stimulation by soluble agonists
Washed platelets were stimulated in an aggregometer at 37°C with thrombin (1 U/ml); the 
selective PAR1-activating peptide (PAR1-AP), SFLLRN (40 μM); or PAR4-AP, AYPGKF (250 
μM). In some experiments, adrenaline (10 μM) was added to the platelets at the same time as 
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the PAR agonist.
 6.2.3. Incubation with inhibitors
The monoclonal antibody AK2, which blocks the VWF recognition domain of GpIbα (RDI Inc. 
Flanders, NJ, USA) and the monoclonal antibody 5D2, which binds to VWF and blocks it from 
binding GpIbα (a generous gift from Michael Berndt, Monash University, Clayton, Victoria, 
Australia) were used at saturating concentrations (De Luca et al., 2000); mouse IgG was used 
as a control (Santa Cruz, Santa Cruz, CA, USA); to block αIIbβ3 we used the synthetic peptide 
RGDS (Sigma, St. Louis, MO, USA), the previous inhibitors were incubated with platelets for 
15 minutes before stimulation. PI3K inhibitors 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-
4-one (LY294002, 10 μM) (Vlahos et al., 1994) or wortmannin (100 nM) (Ui et al., 1995) 
were used at concentrations known to inhibit all known PI3Ks (Rittenhouse, 1996); tyrosine 
kinase inhibitor, piceatannol (25 μg/ml), was used at a concentration known to inhibit Syk, 
FAK and Src (Law et al., 1999) (Calbiochem, San Diego, CA, USA); the P2Y
12
 antagonist 
AR-C69931MX N6-(2-methylthioethyl)-2-(3,3,3-trifluoropropylthio)-β,γ-dichloromethylene-
ATP (ARMX; 1 μM) (generously provided by AztraZeneca, Loughborough, UK); or the P2Y
1
 
antagonist adenosine 3,5 diphosphate (A3P5P; 1 mM) were used at concentrations that saturated 
their targets (Gachet, 2001) (Sigma); all the previous inhibitors were incubated with platelets 
for 10 min before stimulation.  When appropriate, equivalent volumes of DMSO (vehicle for 
LY294002 and wortmannin) were added in the controls. 
6.3. Immunoprecipitations
Resting and stimulated platelets were lysed in an equal volume of ice-cold 
radioimmunoprecipitation assay buffer (2% Triton X-100, 2 mM Na
3
VO
4
, 2 mM NaF, 20 mM 
EDTA, 2 mM PMSF, 2 mg/ml deoxycholic acid, and 20 μg/ml of each aprotinin, leupeptin 
and pepstatin A) and briefly sonicated to help disrupt the platelet membrane. Samples were 
spun at 15000g to for 15 min. to clear the sample from insoluble materials and the supernatant 
recovered and incubated with the appropriate antibody for 1 h, after which protein A or G was 
added and samples incubated for another 2 h.  Samples were washed 4 times with ice-cold PBS 
and immunoprecipitated proteins resuspended by the addition of 60 μl 2X lyses buffer followed 
by boiling. PI3K-IA was immunoprecipitated using the mouse monoclonal anti-p85 antibody 
(clone AB6), which reacts with the α isoform (UBI, Lake Placid, NY, USA), rabbit antiserum 
against p110α or p110β (generously provided by Dr. C. H. Heldin, Ludwig Institute for Cancer 
Research, Uppsala, Sweden); GpIbα was immunoprecipitated with the monoclonal antibody 
AN51 (Dako, Carpinteria, CA, USA); isotype-specific mouse IgG and non-immune rabbit 
antiserum were used as controls.
 6.4. Western blotting
Protein lysates were separated in 7.5% or 10% SDS-PAGE and transferred to nitrocellulose 
membranes. Membranes were blocked with 5% nonfat milk for 1 h at room temperature and 
incubated with the primary antibody at 4oC overnight. This was followed by incubation with 
the secondary antibody at room temperature for 1 h.  After washing, immunoreactive bands 
were developed by enhanced chemiluminescence (ECL; Amersham, Piscataway, NJ, USA). 
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The blotting antibodies used were mouse monoclonal anti-phosphotyrosine - 4G10; anti-p85α - 
AB6; rabbit antiserum against the p85 subunit of PI3K (UBI); against p110α and against p110β; 
anti-phospho-Akt serine (Ser473) or threonine (Thr308) (Cell signaling, Beverly, MA, USA); 
anti-Akt (Santa Cruz Labs); anti-GpIbα – WM23 (generously provided by Michael Berndt); 
anti-PI(4,5)P
2
 (Assay Designs, Ann Arbor, MI, USA); anti-α-actinin – BM.75.2 (Sigma); anti-
Syk – 4D10 (Santa Cruz Labs). PIP
2
 binding to α-actinin was identified by stripping and re-
probing PI(4,5)P
2
 blotted membranes with the antibody specific for α-actinin. Phosphorylated 
Syk was identified by stripping and re-probing anti-phosphotyrosine blotted membranes with 
anti-Syk. Blots were quantified using a Gel Doc 2000 gel documentation system (Bio-Rad, 
Hercules, CA, USA).
 6.5. Analysis of lipids
 6.5.1. PI(3,4,5)P
3
 production in platelets
Resting and shear stress-activated 32P-labeled platelets were immediately mixed with an ice-cold 
mixture of methanol/chloroform/HCl (8:8:1, v/v/v). Lipids were extracted using the method of 
Bligh and Dyer (BLIGH and DYER, 1959), and dried under a stream of N
2
. Dried lipids were 
reconstituted in 50 μl of chloroform and spotted on Silica Gel G thin layer chromatography 
plates pretreated with 1% potassium oxalate. Plates were developed in a solution of chloroform/
methanol/NaOH/H
2
O (60:47:11:2) and dried. Bands were visualized by autoradiography, and 
individual lipids were scraped from the thin layer chromatography plate and quantified by 
liquid scintillation counting. PI(3,4,5)P
3
 lipid standards (Matreya Inc., Pleasant Gap, PA) were 
visualized by spraying the plates with molybdenum blue.
 6.5.2. In vitro PI3K assays
PI3K-IA was immunoprecipitated from platelets activated by shear (120 dynes/cm2) for 120 
seconds.  After immunoprecipitation, samples were washed three times in buffer A (137 mM 
NaCl, 20 mM Tris-HCl pH 7.4, 1 mM MgCl
2
, 1 mM CaCl
2
, and 0.1 mM NaVO
4
), twice in 
buffer B (100 mM Tris-HCl pH 7.4, 5 mM LiCl, and 0.1 mM NaVO
4
) and three times in assay 
buffer (10 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, and 0.1 mM NaVO
4
).  Samples 
were finally resuspended in 20µl assay buffer to which 5 µl ATP mix (750 µM ATP, 20 mM 
MgCl
2
, 25 µCi γ32P-ATP) and 25 µl of substrate (purified α-actinin (5 μg), PI(4,5)P
2
 (100 μM) 
or a mixture of the two) were added.  Samples were incubated at 37oC for 10 minutes and the 
reactions stopped by adding 20 µl of 6 M HCl.  Lipids were extracted by adding 160 µl of 
chloroform:methanol (1:1 vol/vol), separated and measured as described above.
 
 6.6. Expression of the GpIb-IX complex in Chinese hamster ovary cells
Recombinant wild-type and mutant GpIbα, co-expressed with recombinant GpIbβ and GpIX in 
Chinese hamster ovary (CHO) cells were prepared as previously described (Feng et al., 2000).
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7. Results and Discussion
7.1. Phosphatidylinositol 3-kinase in shear stress-stimulated 
platelets
Results from this section are recapitulated in Figure 11.
To investigate the possible activation of PI3K in shear stress-induced platelet responses we 
measured the levels of PI(3,4,5)P
3
 after platelets were exposed to pathological levels of shear 
stress (120 dynes/cm²).
 7.1.1. Shear stress induces phosphatidylinositol (3,4,5)P
3
 synthesis
Platelets synthesize PI(3,4,5)P
3
 within 30 s of exposing them to pathological levels of shear 
stress (Study II, Fig. 1). This production is dependent upon VWF binding GpIb-IX-V as 
the antibody AK2 (6 μg/ml), which binds to GpIbα and prevents VWF-GpIbα interactions, 
abolishes PI(3,4,5)P
3
 production induced by shear stress (Study III, Fig. 1). This results 
suggest that VWF binding to GpIbα directly signals the activation of PI3K, such activation 
has been previously suggested by Jackson et al who reported PI3K activation downstream of 
ristocetin-induced VWF-GpIbα interactions (Jackson et al., 1994). However, this binding is not 
physiological (not-shear dependent) and can trigger different signals to those elicited by shear 
stress-induced VWF binding (Sun et al., 2004). Our results show that pathophysiological levels 
of shear stress cause GpIb-IX-V-dependent PI3K activation.
The PI3K inhibitors wortmannin (100 nM) or LY294002 (10 μM) abolish shear-induced 
PI(3,4,5)P
3 
production (Study II, Fig. 1), which confirms PI(3,4,5)P
3
 production as a result 
of PI3K activation.  When platelets are subjected to shear stress for longer periods of time, 
biphasic PI(3,4,5)P
3 
production occurs peaking at ~ 60 and 180 seconds (Study III, Fig. 
1). The significant function of this biphasic production of PI(3,4,5)P
3
 is at this time unclear 
but data from previous reports support a functional consequence for these events. The rapid 
accumulation of D3-phosphoinositides regulates platelet functions such as platelet adhesion 
and Ca2+ mobilization (Yap et al., 2002), platelet shape change (actin assembly) (Hartwig et 
al., 1996;Hartwig et al., 1995), and the activation of platelet PLCγ2 (Bae et al., 1998;Gratacap 
et al., 1998;Pasquet et al., 1999). This rapid accumulation may also direct the shear-induced 
dissociation of α-actinin from αIIbβ3 (Study I, Fig. 4), as it occurs in rat fibroblast where 
the PI(3,4,5)P
3
 levels direct the dissociation of α-actinin from the β3 tail of αvβ3, which 
might moderate the binding properties of these receptors (Greenwood et al., 2000). The 
pathophysiological role of the second peak of PI(3,4,5)P
3
 production is at this time uncertain 
since this peak occurs minutes after platelets are exposed to shear stress. Although suspended 
circulating platelets are not exposed to such long periods of shear stress, platelets accruing to 
an injured site are most certainly exposed to shear stresses that can be extremely high and for 
long periods of time. Thus, we believe the second peak of PI(3,4,5)P
3
 regulates an important 
proaggregatory signal, the activation/expression of αIIbβ3 in order to form stable platelet 
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aggregation.
 7.1.2. Platelet aggregation partially depends on PI3K activation
To study the contribution of PI3K to shear stress-induced platelet aggregation, platelets 
were treated with wortmannin or LY294002 at the concentrations that abolished PI(3,4,5)P
3
 
production. Inhibiting PI3K activation causes inhibition of shear stress-induced platelet 
aggregation confirming an important supportive role for PI3K in sustaining platelet aggregation 
induced by shear stress (Study II, Fig. 1). Accordingly, recent studies in static conditions 
place PI3K as an important mediator of αIIbβ3 activation downstream of VWF/GpIb-IX-V 
(Kasirer-Friede et al., 2004) and in studies under shear stress conditions, inhibition of PI3K 
results in impaired thrombus growth (Yap et al., 2002). Moreover, deletion of PI3Kγ in mice 
confer these mice protection against the development of vascular occlusion when the mice are 
challenged with infusions of ADP (Hirsch et al., 2001). Taken together these studies confirm 
that under shear stress conditions, the prolonged activation of PI3K (second peak of PI(3,4,5)P
3
 
production) is an important event that maintains αIIbβ3 in an active conformation to stabilize 
platelet aggregation. 
 7.1.3. Tyrosine phosphoproteins regulate PI3K activation
One of the main mechanisms of PI3K-IA activation is its association with regulatory tyrosine-
phosphorylated proteins (Wymann and Pirola, 1998). To determine if shear-dependent 
PI(3,4,5)P
3
 production results from a phosphotyrosine-dependent activation of a type IA PI3K, 
platelets were treated with piceatannol (25 μg/ml), a tyrosine kinase inhibitor that is known to 
inhibit Src, Syk and FAK (Law et al., 1999). Piceatannol treatment abolishes shear-induced 
PI(3,4,5)P
3
 production (Study II, Fig. 2) indicating that tyrosine-phosphorylated proteins 
play an important role in modulating PI3K activation. Next we tried to identify the tyrosine-
phosphorylated proteins involved in PI3K activation.
 I. Phosphorylated Syk associates with PI3K-IA
There is evidence that the tyrosine kinase Syk is phosphorylated downstream of VWF-GpIbα 
interactions in sheared platelets (Kasirer-Friede et al., 2002;Razdan et al., 1994) and that it 
activates PI3K-IA in B lymphocytes (Beitz et al., 1999) and natural killer cells (Jiang et al., 
2002;Jiang et al., 2003). To test the hypothesis that Syk is involved in PI3K-IA activation, 
immunoprecipitations of PI3K-IA were performed. Study II, Figure 2 shows that Syk co-
immunoprecipitates with PI3K-IA in resting platelets and that pathological shear stress 
stimulates the phosphorylation of Syk associated with PI3K-IA. Piceatannol inhibits the 
tyrosine phosphorylation of Syk co-immunoprecipitated with PI3K-IA but does not affect 
the association between Syk and PI3K-IA. These results suggest that phosphorylated Syk 
modulates PI3K-IA activation. However, we can not be sure that all PI3K-IA activity depends 
on its association with tyrosine-phosphorylated Syk since piceatannol affects other platelet 
tyrosine kinases in addition to Syk (Law et al., 1999), furthermore, several other tyrosine-
phosphorylated proteins associate with PI3K-IA (Resendiz et al., 2001). Yet, it is likely that Syk 
plays a major role in PI3K-IA activation as it does in other cells (Beitz et al., 1999;Jiang et al., 
2002;Jiang et al., 2003).
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In addition to blocking PI3K activation, piceatannol also inhibits platelet aggregation (Study I, 
Fig. 6A), and while tyrosine kinases may direct several platelet responses, one explanation for 
piceatannol effects on platelet aggregation is the subsequent inhibition of PI3K-IA altering the 
ligand-binding properties of αIIbβ3.
 7.1.4. ADP regulates PI(3,4,5)P
3
 synthesis
Shear-dependent platelet adhesion and aggregation depend on released ADP binding to both 
P2Y
1
 and P2Y
12
 receptors (Mazzucato et al., 2004;Turner et al., 2001). To determine if shear-
induced platelet aggregation and PI3K activation is caused by a rapid feedback mechanism 
that involves secreted ADP binding to one or both of its receptors, platelet aggregation and 
PI(3,4,5)P
3
 synthesis were analyzed after washed platelets were pretreated with an antagonist 
against the P2Y
1
 (A3P5P, 100 μM) or P2Y
12
 (ARMX, 0.5 μM) receptors. ARMX has a 
significant inhibitory effect on platelet aggregation at 30 and 60 s, while A3P5P has a non-
significant effect, although a trend can be seen (Study II, Fig. 3). Shear-induced PI(3,4,5)P
3
 
synthesis is inhibited by blocking the P2Y
12
 receptor, but blocking P2Y
1
 has no effect at 30 
s and only a modest effect at 60 s of shear stress (Study II, Fig. 3). These results are not 
surprising since it is generally accepted that P2Y
12
 signals the activation of PI3Kγ (PI3K-
IB) through the dissociation of Giα from Giβγ, where the βγ subunits activate PI3Kγ (Hirsch 
et al., 2001;Stephens et al., 1994). What is surprising is the fact that PI3Kγ is not activated 
by tyrosine-phosphorylated proteins and as mentioned in section 7.1.3, this seems to be an 
important mechanism in shear-induced PI3K activation since treatment with piceatannol 
abolishes PI(3,4,5)P
3
 production. This raises the possibility that a PI3K-IA might be activated 
downstream of P2Y
12
, a possibility suggested in other experimental systems (Okada et al., 
1996;Tang and Downes, 1997;Thomason et al., 1994).
 I. P2Y
12
 signals PI3K-IA-associated-Syk phosphorylation
To test the hypothesis that P2Y
12
 signals the activation of PI3K-IA, we scrutinized for 
phosphorylated Syk associated with PI3K-IA immunoprecipitated from sheared platelets treated 
with ARMX or A3P5P. ARMX, but not A3P5P, inhibited the tyrosine phosphorylation of Syk 
associated with PI3K-IA (Study II, Fig. 4). These results show that Syk phosphorylation 
induced by shear stress is the result of secreted ADP feedback binding to its P2Y
12
 receptor. The 
results provide new evidence that P2Y
12
 also delivers a proaggregatory signal that involves the 
activation of tyrosine-phosphorylated proteins followed by the stimulation of PI3K-IA. These 
observations are in agreement with previous reports, for example, Hirsch et al published that in 
PI3Kγ deficient mice the phosphorylation of Akt induced by ADP is strongly inhibited (70%), 
but not abolished (Hirsch et al., 2001), and Lova et al observed that adrenaline or ADP stimulate 
Rap1B via a PI3K-dependent pathway in PI3Kγ KO mice (Lova et al., 2003). Moreover, 
Jackson et al developed a specific inhibitor of PI3K-IA (p110β isoform) such a compound 
inhibits platelet responses to ADP, and interestingly, prevents occlusive thrombus formation in 
an arterial injury model in rats and rabbits (Jackson et al., 2005). Thus, we conclude that P2Y
12
 
signals the activation of both types PI3Kγ and PI3K-IA; moreover, these signals are vital to 
thrombus stabilization under rheological conditions of high shear stress.  
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Figure 11. Events leading to the activation of PI3K in shear stress-stimulated platelets. Shear-
induced VWF binding to GpIbα induces a rise in intracytoplasmic Ca2+ and the activation of PKC 
causing platelet secretion. Secreted ADP binds P2Y
12
 and activates protein tyrosine kinases (PTK) 
among them Syk, which bind and activate PI3K-IA. Activated PI3K-IA synthesizes PI(3,4,5)P
3
, 
which signals actin assembly and the activation of αIIbβ3 to cause platelet aggregation. Molecules 
inside stars indicate activation. Pathways suggested from our work are highlighted in red.
7.2. α-Actinin-PI3K-IA signaling complex
Results from this section are recapitulated in a model presented in Figure 12.
After identifying Syk as one of the partners that regulates shear-induced PI3K-IA activation, we 
attempted to elucidate additional factors involved in shear-dependent PI(3,4,5)P
3
 production.  
We focused on α-actinin because previous reports have shown that α-actinin binds to PI(4,5)P
2
 
and this binding regulates its activity (Fukami et al., 1992); furthermore, α-actinin is able 
to bind PI3K-IA, and this binding is enhanced by PI(4,5)P
2
 (Shibasaki et al., 1994). We 
hypothesized that α-actinin serves as an adapter protein co-localizing substrate PI(4,5)P
2
 with 
PI3K-IA, and that co-localization regulates shear-induced PI(3,4,5)P
3
 production. 
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 7.2.1. Shear stress induces a dynamic association between α-actinin and PI3K-IA
To examine for the assembly of an α-actinin-based molecular signaling complex that includes 
PI3K-IA and PI(4,5)P
2
, we performed immunoprecipitations of PI3K-IA. In resting platelets 
PI3K-IA co-immunoprecipitates with α-actinin-PI(4,5)P
2
, after exposure to 120 dynes/cm² 
shear stress a dynamic association between these molecules occurs. Within the first 30 to 60 s 
of exposure to shear stress, α-actinin and PI(4,5)P
2
 disassociate from PI3K-IA.  Between 60 and 
120 s after beginning shear stress, both α-actinin and PI(4,5)P
2
 re-associate with PI3K-IA.  The 
maximal association between PI3K-IA, α-actinin, and PI(4,5)P
2
 develops at 180 seconds (Study 
I, Fig. 8 and Study III, Fig. 2).  These results demonstrate that α-actinin compartmentalizes 
substrate PI(4,5)P
2
 with PI3K-IA.  In addition, as previously mentioned in section 7.1.1, we 
observed that shear stress-induced PI(3,4,5)P
3
 production is biphasic (peaks at ~ 60 and 180 
seconds) (Study III, Fig. 1), and a temporal relation between this production and the PI3K-
IA-α-actinin-PI(4,5)P
2
 complex exists. These results suggest that the association of these three 
molecules regulates shear-induced PI(3,4,5)P
3
 production.  The clear correlation between the 
first PI(3,4,5)P
3
 peak and the dissociation of α-actinin from PI3K-IA allows us to speculate 
that while PI3K-IA forms a complex with α-actinin/PI(4,5)P
2
 in resting platelets; PI3K-IA is 
not able to use the PI(4,5)P
2
 because one factor is required, the activation of Syk and tyrosine 
kinases associated with PI3K-IA, and these proteins don’t become activated until after shear-
induced VWF binding to GpIbα occurs (Study II, Figs. 2, 3). Then, activated PI3K-IA might 
utilize the substrate bound PI(4,5)P
2
/α-actinin to synthesize PI(3,4,5)P
3
.
 I. PI3K-IA synthesizes PI(3,4,5)P
3
  from PI(4,5)P
2
 bound to α-actinin     
To test the hypothesis that the association between PI3K-IA, α-actinin, and PI(4,5)P
2
 regulates 
shear-induced PI(3,4,5)P
3
 production; we examined if their co-localization regulates PI(3,4,5)P
3
 
synthesis in a cell-free system. Different amounts of PI(4,5)P
2
 were incubated with α-actinin 
and α-actinin was immunoprecipitated. We observed that purified PI(4,5)P
2
 binds directly 
to purified α-actinin, as detected by immunoblotting for PI(4,5)P
2
 (Study III, Fig. 4). To 
examine if α-actinin co-localizes and thereby regulates the phosphorylation of PI(4,5)P
2
 
by PI3K-IA, we measured in vitro PI(3,4,5)P
3
 production using platelet PI3K-IA incubated 
with immunoprecipitations of α-actinin from three different mixtures: α-actinin, PI(4,5)P
2
, 
or α-actinin + PI(4,5)P
2
.  Study III, Figure 5 shows that purified α-actinin alone or purified 
PI(4,5)P
2
 alone fails to stimulate in vitro PI(3,4,5)P
3
 production.  By contrast, when purified α-
actinin is preincubated with PI(4,5)P
2
 and the complex is added to PI3K-IA, in vitro PI(3,4,5)P
3
 
production occurs.  These results prove that α-actinin is capable of regulating PI3K-IA activity 
by co-localizing it with substrate PI(4,5)P
2
. Collectively, the findings allow us to speculate how 
the dynamic associations between α-actinin and PI3K-IA regulate PI(3,4,5)P
3
 production.  The 
depletion of substrate PI(4,5)P
2
 by active PI3K-IA drives the first PI(3,4,5)P
3
 production peak 
and the rapid disassembly of the α-actinin/PI(4,5)P
2
-PI3K-IA complex. The second PI(3,4,5)P
3
 
production peak is regulated by the co-localization of “new” α-actinin-PI(4,5)P
2
 with activated 
PI3K-IA, the location of this complex in the cell is not known, but we presume that it occurs 
in the cytoskeletal compartment since upon platelet activation several molecules move to this 
compartment (Jennings et al., 1981;Fox, 2001).
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 7.2.3. Shear induces α-actinin association with the GpIb-IX-V complex
Shear-induced platelet responses are initiated by the binding of VWF to GpIb-IX-V and this 
interaction directs platelet signaling to the actin cytoskeleton through GpIbα association with 
filamin A (Christodoulides et al., 2001;Feng et al., 2003). α-Actinin is an important member 
of the cytoskeleton that cross-links actin filaments and is able to associate with many different 
proteins (Otey and Carpen, 2004;Djinovic-Carugo et al., 1999). In study I, we found that α-
actinin co-immunoprecipitates with GpIbα (Study I, Figs. 1,2). This interaction is dependent 
upon VWF-GpIb-IX-V interactions (Study I, Fig. 3) and occurs through the GpIbα-filamin 
A-actin cytoskeleton connections as treatment with DNase I, which disrupts filamin-actin 
interactions, inhibits GpIbα-filamin-actin-α-actinin association (Study I, Fig. 5). These 
interactions may serve to localize the formation of complexes around the cytoplasmic tail 
of GpIbα to maintain actin polymerization and platelet aggregation (Christodoulides et al., 
2001;Fox, 2001). Another possible function is the localization of PI3K-IA to this compartment 
to facilitate access to substrate.
 I. PI3K-IA associates with GpIb-IX-V through the cytoskeleton
There is evidence that PI3K binds to GpIbα through GpIbα’s C-terminal interaction with 14-
3-3ζ (Munday et al., 2000). As we found a shear-induced association between GpIb-IX-V and 
α-actinin, and an association between α-actinin and PI3K-IA that are maximal after platelets 
have been exposed to a long period (180 s) of shear stress, we hypothesized that PI3K-IA 
binds to GpIbα through its cytoskeletal connections. To test this hypothesis we used CHO 
cells expressing wild type or mutant GpIbα co-expressed with recombinant GpIbβ and GpIX. 
When PI3K-IA was immunoprecipitated from CHO cells we found that PI3K-IA remains 
bound to GpIbα594/β/IX (Study III, Fig. 7A) despite that truncation at the residue 594 
eliminates 14-3-3ζ binding to GpIbα (Feng et al., 2000).  The reciprocal immunoprecipitation 
corroborates that PI3K-IA binds to GpIbα truncated of its 14-3-3ζ binding domain (Study 
III, Fig. 7A). To test the effects of shear stress in the GpIb-IX-V-PI3K-IA association, PI3K-
IA was immunoprecipitated from sheared platelets. PI3K-IA associates with GpIbα in resting 
platelets and this association increases upon shear stress stimulation (Study III, Fig. 6). The 
increased association between PI3K-IA and GpIbα is inhibited by the monoclonal antibody 
5D2 (Study III, Fig. 6A), which blocks VWF binding to GpIb-IX-V and inhibits all shear-
induced responses. Munday et al. estimated that the percentage of active PI3K-IA associated 
with GpIb-IX-V in resting platelets is less than 5%, and that VWF stimulation under low shear 
Figure 12. Shear stress induces biphasic PI(3,4,5)P
3
 production that might be regulated by a dy-
namic complex between PI3K-α-actinin-PI(4,5)P
2
. (A) In resting platelets PI3K-IA forms a complex 
with Syk and α-actinin-PI(4,5)P
2
. (B) Upon shear stimulation, Syk and other protein tyrosine kinases 
(PTK) become phosphorylated and activate PI3K-IA, which then synthesizes PI(3,4,5)P
3
 from bound 
PI(4,5)P
2
-α-actinin. PI(3,4,5)P
3
 directs platelet shape change and the activation of αIIbβ3 (C) Once PI3K-
IA utilizes the PI(4,5)P
2
 associated with α-actinin, α-actinin disassociates from PI3K-IA, and the produc-
tion of PI(3,4,5)P
3
 subsides. At the same time α-actinin moves to a compartment at the cytoplasmic tail of 
GpIbα  (D) Upon minutes of shear stress stimulation, activated PI3K-IA moves to the actin-assembling 
cytoskeleton where it encounters new α-actinin carrying PI(4,5)P
2
 and one site where this takes place is 
in a compartment at the cytoplasmic tail of GpIbα. PI3K-IA synthesizes new PI(3,4,5)P
3
, which helps to 
maintain αIIbβ3 in an activated state to stabilize the platelet aggregate. (Opposite page)
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stress conditions increases the association between GpIbα and PI3K-IA in the actin-cytoskeletal 
compartment (Munday et al., 2000). To investigate if shear-induced VWF binding to GpIb-IX-
V causes PI3K-IA to bind platelet GpIbα through an intact filamin A/actin/α-actinin network, 
we examined sheared human platelet lysates treated with DNase I, which disrupts actin/α-
actinin binding to filamin A (Study I, Fig. 5). DNase I eliminates shear-induced GpIbα binding 
to immunoprecipitated PI3K-IA (Study III, Fig. 7B). In short, the previous results show that 
pathological shear stress causes: increase binding of α-actinin to GpIbα (Study I), and increase 
binding of PI3K-IA to GpIbα (Study III) likely through α-actinin, since disrupting actin/α-
actinin binding eliminates the shear stress-induced binding of GpIbα to PI3K-IA. These raise 
the possibility that the second peak of PI(3,4,5)P
3
 production partially occurs in a compartment 
at the cytoplasmic tail of GpIbα. The possibility of such an assembly at the cytoplasmic tail 
of GpIbα could facilitate the translocation of membrane-localized PI(4,5)P
2
 to cytoskeletal 
α-actinin. Such translocation would likely increase the production of PI(3,4,5)P
3
, since upon 
activation by different stimulus including shear stress, PI3K-IA and several tyrosine kinases, 
including Syk, translocate to the cytoskeleton (Fuste et al., 2002;Yanagi et al., 1994;Gachet et 
al., 1997;Rittenhouse, 1996). Thereby the co-localization of enzyme-activator-substrate might 
take place in a GpIbα cytoskeletal compartment. 
7.3. Phosphatidylinositol 3-kinase in thrombin-stimulated 
platelets
Results from this section are recapitulated in Figure 13.
The activation of PI3K in thrombin-stimulated platelets is dependent on ADP secretion and the 
activation of tyrosine kinases (Guinebault et al., 1993;Selheim et al., 1999). Since our results 
on shear stress-stimulated platelets indicate that PI3K activation is also dependent on secreted 
ADP and tyrosine kinases, we decided to study if a similar/redundant mechanism driving 
PI3K activation exists in shear stress- and thrombin-stimulated platelets. Thrombin causes the 
phosphorylation/activation of Akt (Banfic et al., 1998a) and several reports have shown that 
PI3K products fully regulate Akt phosphorylation; therefore, we decided to carefully monitor 
the phosphorylation of Akt and consider it as an indicator of PI3K activation. 
 7.3.1. Thrombin stimulation induces Akt phosphorylation
We used a concentration of thrombin that activates both PAR1 and PAR4 and peptides that 
only activate PAR1 (PAR1-AP) or PAR4 (PAR4-AP); the purpose was to investigate any 
difference in the activation of PI3K downstream of the different thrombin receptors. Platelets 
stimulated with thrombin (1 U/ml), PAR1-AP (SFLLRN, 40 μM), or PAR4-AP (AYPGKF, 
250μM) present similar levels of Akt phosphorylation, thereby indicating the activation of PI3K 
(Study IV, Fig. 1). Akt phosphorylation in response to thrombin or the PAR4-AP is partially 
independent of PI3K activation, as incubation with LY294002, which inhibits specifically all 
PI3K isoforms, causes only partial inhibition of Akt phosphorylation. In contrast, in PAR1-AP 
stimulated platelets, LY294002 eliminates Akt phosphorylation (Study IV, Fig. 2). Although the 
phosphorylation of Akt independently of PI3K was unexpected, these results are consistent with 
previous reports, which show Akt being phosphorylated independently of PI3K (Kroner et al., 
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2000;Scheid and Woodgett, 2003).
 7.3.2. PI3K-IA associates with tyrosine-phosphorylated proteins upon PAR-
stimulation
To begin investigating mechanisms of PAR-induced PI3K-IA activation we first considered that 
PI3K activation in thrombin-stimulated platelets is dependent on tyrosine kinases (Guinebault et 
al., 1993) and that PI3K-IA is modulated by its association with tyrosine kinases in shear stress-
activated platelets (study II) (Resendiz et al., 2001). To investigate if a similar mechanism of 
PI3K activation occurs in response to PARs, we performed immunoprecipitations of PI3K-IA 
and looked for co-precipitating tyrosine-phosphorylated proteins.  We observe that thrombin, 
PAR1-AP and PAR4-AP cause PI3K-IA to associate with tyrosine-phosphorylated proteins 
of ~ 75, 90 and 100 kDa (Study IV, Fig. 6). The 75 kDa band is immunoblotted by a specific 
antibody against Syk, the 90 kDa is most probably the p85 subunit of PI3K-IA, and the band of 
~ 100 kDa has not yet been identified, but by immunoblotting does not appear to be α-actinin as 
we expected based in our results in shear stress-stimulated platelets. One possibility is that the 
antibody that we use does not recognize α-actinin when phosphorylated. 
The classical mode of PI3K-IA activation is its association with transmembrane receptors 
or cytoskeletal proteins containing tyrosine phosphorylation motifs (pYXXM) (Wymann 
and Pirola, 1998). In platelets, the hypothesis that phosphotyrosine motifs regulate PI3K-IA 
activation in thrombin-stimulated platelets is supported by the studies of Guinebault et al who 
reported that thrombin-induced accumulation of D3-phosphoinositides is dependent on the 
activation of tyrosine kinases (Guinebault et al., 1993). In agreement with those observations, 
we have observed that treatment of platelets with Piceatannol, a different tyrosine kinase 
inhibitor than the one used by Guinebault et al, inhibits the phosphorylation of Akt. Moreover, 
our studies take the previous observations a step further by analyzing the molecules that become 
tyrosine-phosphorylated and regulate PI3K-IA activation. First, the p85 subunit of PI3K-IA is 
phosphorylated and this subunit associates with tyrosine-phosphorylated Syk.
 7.3.3. Role of ADP in the regulation of PI3K activation downstream of PARs
PAR activation causes secretion of dense granule ADP and released ADP amplifies the PAR 
response (Selheim et al., 1999;Trumel et al., 1999). In shear stress-activated platelets, ADP 
directs the activation of PI3K-IA by regulating the phosphorylation of PI3K-IA-associated 
proteins (Study II). We therefore investigated the possibility of a similar mechanism operating 
in platelets stimulated by PARs.
 I. ADP regulates PI3K-IA association with tyrosine-phosphorylated proteins in 
platelets stimulated thought PAR1
Platelets were incubated with the specific inhibitors of P2Y
1
 and P2Y
12
 and the effects of 
these blockades on the co-precipitation of tyrosine-phosphorylated proteins with PI3K-IA was 
examined.  Treatment with ARMX inhibits the tyrosine phosphorylation of the p85 subunit and 
its associated proteins in PAR1-AP-stimulated platelets, but has no effect in thrombin- or PAR4-
AP-stimulated platelets.  A3P5P does not influence the tyrosine phosphorylation of proteins 
46
RESULTS AND DISCUSSION
47
RESULTS AND DISCUSSION
co-immunoprecipitated with PI3K-IA under all experimental conditions (Study IV, Fig. 7). 
Previously, Selheim at al reported that thrombin-induced D3-phosphoinositide production is 
largely dependent on ADP secretion (~80%) (Selheim et al., 1999). Our results are consistent 
with their conclusion and further show that the remaining synthesis of D3-phosphoinositides 
is downstream of the PAR4 receptor and is the result of tyrosine-phosphorylated proteins 
activating PI3K-IA.
 II. P2Y
12
 regulates Akt phosphorylation induced by PAR stimulation
To investigate the role of purinergic receptors on the activation of PI3K, we measured the 
effects of purinergic receptor blockade on Akt phosphorylation.  We observed that ARMX 
abolishes Akt phosphorylation in response to PAR1-AP but a significant amount of residual 
Akt phosphorylation remains after PAR4 stimulation in the presence of the P2Y
12
 blocker (~ 
20-30% at 120 s and ~ 30-40% at 300 s) (Study IV, Fig. 3).    This figure also shows that when 
platelets are pre-incubated with the P2Y
1
-specific inhibitor A3P5P, the phosphorylation of Akt 
in response to all agonists is unaffected.  These data indicate that the P2Y
12
 receptor is required 
for the phosphorylation of Akt in PAR1-stimulated platelets but that Akt phosphorylation in 
response to thrombin or PAR4 partially bypasses P2Y
12
.  Accordingly, P2Y
12
 blockade or PI3K 
inhibition causes reversible platelet aggregation only when platelets are stimulated with PAR1-
AP, but not thrombin or PAR4-AP (Study IV, Fig. 4). These results confirm that PAR1-induced 
platelet aggregation relies on P2Y
12
-dependent PI3K activation leading to Akt phosphorylation 
(Lau et al., 1994;Jin and Kunapuli, 1998;Kovacsovics et al., 1995;Trumel et al., 1999).  In 
contrast, PAR4-induced platelet aggregation, like Akt phosphorylation, circumvents P2Y
12
-
dependent PI3K activation.
PAR-induced accumulation of D3-phosphoinositides is strongly dependent upon ADP secretion 
(Selheim et al., 1999;Selheim et al., 2000b;Selheim et al., 2000a). We confirmed these results 
by showing that phosphorylation of Akt triggered by PAR1 is totally and PAR4 partially 
dependent upon ADP secretion. Moreover, when we searched for the specific ADP receptor 
that signals Akt phosphorylation, we find it to be P2Y
12
. The effect of P2Y
12
 blockade on 
PI3K activity probably accounts for most if not all the inhibition seen when ADP is removed 
by phosphocreatine/creatine phosphokinase (Selheim et al., 2000b). Stimulated PAR4 causes 
platelet aggregation independently of ADP, our results provide an explanation to this finding 
by showing that PAR4, but not PAR1 activates PI3K independently of ADP, thereby PI3K is 
able to maintained αIIbβ3 activated, This gets more complicated since we see that PAR4 is in 
fact able to generate stable platelet aggregation independently of the PI3K-Akt pathway. These 
results leave us with two possibilities either αIIbβ3 can be activated and maintained in that way 
independently of PI3K and Akt activation or a second possibility is generated by our results 
that show that PAR4 activates Akt independently of PI3K, thereby, Akt would still be able to 
activate αIIbβ3 to stabilize platelet aggregation. 
III. Gi proteins stimulate Akt phosphorylation and PI3K-IA activation
The P2Y
12
 receptor for ADP and the α2 adrenergic receptor for adrenaline are both associated 
with heterotrimeric G proteins of the Gi family.  P2Y
12
 is associated with Gi and the α2 
receptor is coupled to Gz. Because these two receptors induce similar signaling events, each 
is capable of overcoming the blockade of the other (Gratacap et al., 2000;Jin and Kunapuli, 
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Figure 13. Events leading to the activation of PI3K in thrombin-stimulated platelets. Stimulated 
PAR1 causes platelet secretion and transient activation of protein tyrosine kinases (PTK) among them 
Syk, which bind and activate PI3K-IA. Secreted ADP stimulates P2Y
12
 activating PTK, which bind 
and maintain PI3K-IA in an activated state. PAR4 stimulation causes platelet secretion and a weak-
sustained activation of PI3K-IA, but secreted ADP binding P2Y
12
 strongly feedbacks PI3K activation.  
Activated PI3K synthesizes PI(3,4)P
2
 and PI(3,4,5)P
3
, which signal the activation of PDK-1 and Akt. 
Together these signals modulate platelet shape change and activate αIIbβ3.  Molecules inside stars 
indicate activation. Pathways suggested from our work are highlighted in red. 
1998;Mustonen et al., 2001).  We utilized the redundancy between platelet P2Y
12
 and α2 
receptors as a tool to explore the involvement of a Gi signaling pathway in the phosphorylation 
of Akt induced by PAR agonists.  Platelets were incubated with the P2Y
12
 inhibitor ARMX and 
then stimulated with a PAR agonist simultaneously with adrenaline for 300 s. ARMX-induced 
inhibition of Akt phosphorylation is recovered by adrenaline co-stimulation (Study IV, Fig. 
8).  Akt phosphorylation recovery is most prominent in platelets stimulated with PAR1-AP 
plus adrenaline, although the recovery of Akt phosphorylation by adrenaline co-stimulation 
in thrombin or PAR4-AP stimulated platelets is also evident. To investigate if adrenaline also 
overcomes the effect of P2Y
12
 blockade on the tyrosine-phosphorylated proteins associated with 
PI3K-IA; we stimulated ARMX pre-treated platelets with PAR1-AP plus adrenaline and then 
examined immunoprecipitates of PI3K-IA for co-precipitating tyrosine-phosphorylated proteins. 
The phosphorylation of the PI3K-IA-associated proteins and that of the p85 subunit is restored 
by adrenaline co-stimulation (Study IV, Fig. 9). These results highlight the importance of Gi in 
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stimulating PI3K-IA activity and Akt phosphorylation in PAR1-induced platelet responses.
There is irrefutable evidence that Gi proteins abrogate platelet adenylyl cyclase activity and 
there is evidence that Gi
2
 coupled to P2Y
12
 conveys other proaggregatory signals. One such 
signal involves Giβγ-activation of PI3Kγ (Hirsch et al., 2001;Selheim et al., 1999;Selheim 
et al., 2000a;Stephens et al., 1994). Data presented here provide new evidence that Gi also 
delivers a proaggregatory signal that involves the activation of tyrosine-phosphorylated proteins 
followed by the stimulation of PI3K-IA. Interestingly, Okada et al. showed that in rat liver p85α 
forms heterodimers with p110β and this complex is synergistically activated by Gβγ subunits 
and a tyrosine-phosphorylated peptide (Kurosu et al., 1997;Okada et al., 1996). To investigate 
if this can occur in human platelets, we examined immunoprecipitated platelet p85α for co-
precipitating p110β.  Study IV, Figure 10 shows that the p85α subunit forms heterodimers 
with both the p110 α and β subunits.  These results are consistent with data demonstrating that 
platelet PI3K-IA is dually regulated by engaging both phosphotyrosine containing proteins and 
Gβγ subunits.   
Recently, Chan et al proposed an elegant model for PI3K-IA activation, a dual modulation 
by GTPases and tyrosine kinases (Chan et al., 2002). PI3K-IA is stimulated through a 
GTPase responsive domain, but an inhibitory domain present in the p85 subunit suppresses 
this stimulation. Tyrosine kinases direct the phosphorylation of the p85 subunit causing the 
neutralization of the inhibitory domain, our data shows that p85 becomes phosphorylated after 
PAR stimulation and others have shown an association between Rho-GTPase and PI3K-IA 
(Zhang et al., 1993) suggesting that the model proposed by Chan et al might be present in 
human platelets.
7.4. Synopsis of the results
In summary, our analysis of the activation of PI3K triggered by two platelet agonists present 
under physiological and pathophysiological conditions, shear stress and thrombin, brought the 
following results (Fig. 14).
1. PI3K is activated in shear stress and thrombin-stimulated platelets
2. Shear stress- and PAR1-induced platelet aggregation depends on PI3K activation; on the 
other hand PI3K activation is not necessary for PAR4-induced platelet aggregation.
3. PI3K-IA activation depends on its association with tyrosine-phosphorylated proteins.
4. ADP is an essential cofactor in the activation of PI3K in shear stress- and thrombin-
stimulated platelets. Specifically the P2Y
12
 receptor coupled to Gi.
5. Shear stress stimulates biphasic PI(3,4,5)P
3
 production – α-actinin carrying PI(4,5)P
2
 
forms a shear stress-induced dynamic complex with PI3K-IA; a complex that may regulate 
PI(3,4,5)P
3
 production.
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Figure 14. Shear stress-induced thrombus formation – involvement of PI3K. Shear-induced VWF 
binding to GpIbα induces platelet secretion, secreted ADP activates PI3Kγ and PI3K-IA, which synthesize 
PI(3,4,5)P
3
. A pool of the PI(3,4,5)P
3
 comes from PI3K-IA consuming PI(4,5)P
2
 bound to α-actinin. Acti-
vated platelets expose phospholipids in their surfaces and thrombin generation ensues, locally generated 
thrombin cleaves PAR receptors causing full platelet degranulation. Stimulated PARs directly and through 
secreted ADP activate PI3K. Activated PI3K generates D3-phosphoinositides (PI(3,4)P
2
 and PI(3,4,5)P
3
), 
which direct actin polymerization and activate PDK-1 and Akt. Activated PDK-1 and Akt phosphorylate 
the β3 tail of αIIbβ3 allowing it to bind VWF and fibrinogen to cause platelet aggregation. Molecules 
inside stars indicate activation.
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8. Conclusions 
Mechanisms of platelet activation-aggregation are multiple and complex; it is impossible to 
precisely rank the importance of each proaggregatory signal triggered by platelet agonists. 
However, certain facts should be considered when studying proaggregatory signaling pathways, 
such as the evidence that in mid-size arteries affected by atherosclerosis, platelet-dependent 
thrombosis is controlled by the rheological forces (high shear stress) present at the site.  Hence, 
an ideal therapy to prevent arterial thrombosis aims at controlling pathological shear stress-
induced platelet aggregation without interfering with platelet-dependent hemostasis.
One current therapy is the use of clopidogrel, which targets the P2Y
12
 receptor of ADP, and our 
studies provide an explanation onto why this strategy is effective.  Shear stress-induced platelet 
aggregation depends on secreted ADP signaling the activation of PI3K, a signal that is essential 
to stabilize platelet aggregation. However, this therapy has limitations one of them being 
potential bleeding complications, which highlights the potential for improvement.
Our data shows that shear stress- but not thrombin-induced platelet aggregation requires 
PI3K activation. This strengthens previous observations that PI3K is more important in 
the development of arterial thrombosis than in hemostasis. For example, deletion of PI3Kγ 
protects these mice from thromboembolic complications but the mice do not present bleeding 
diathesis (Hirsch et al., 2001), and a specific inhibitor of p110β protects rats and rabbits from 
developing arterial thrombosis without prolonging the bleeding time (Jackson et al., 2005). 
Thus, the development of isoform-specific PI3K inhibitors might be a good strategy to improve 
the treatment of patients at risk of developing thrombosis. Furthermore, our studies provide 
alternatives for not only directly targeting PI3K, also the target might be the upstream molecules 
that confer PI3K activity, and given the important physiological functions that the different 
PI3Ks regulate, it would be ideal to accomplish the inhibition of PI3K only when triggered by 
pathological shear stress. Thus, PI3K inhibitors may prove to be a superior alternative to treat 
patients at risk of developing arterial thrombosis.
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